| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | FOXO1 FOXO3 SATB2 KAT6A ISL1 UPF1 PHF8 MED1 ARID1A FOXA1 FANCM JMJD1C SFMBT2 MEIS1 MLH3 WDHD1 ATXN7 YAP1 PITX2 TOX3 TAF1 PAX6 MBD5 MED12 SMAD4 | 1.08e-10 | 739 | 144 | 25 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO1 FOXO3 SP1 NRIP1 KAT6A ISL1 MED1 ARID1A FOXA1 JMJD1C PTPRT MEIS2 BAZ2A YAP1 PITX2 TAF1 PAX6 MED12 TP73 SMAD4 RBX1 | 1.09e-07 | 753 | 144 | 21 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | SP1 NRIP1 ISL1 MED1 ARID1A FOXA1 JMJD1C PTPRT BAZ2A PITX2 TAF1 MED12 TP73 SMAD4 RBX1 | 3.58e-07 | 417 | 144 | 15 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP1 NRIP1 KAT6A ISL1 MED1 ARID1A FOXA1 JMJD1C PTPRT BAZ2A YAP1 PITX2 TAF1 MED12 TP73 SMAD4 RBX1 | 1.05e-06 | 582 | 144 | 17 | GO:0140297 |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.56e-06 | 120 | 144 | 8 | GO:0008013 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXO1 FOXO3 SP1 SATB2 HIVEP2 ISL1 FOXA1 MEIS1 MEIS2 USF3 PITX2 PAX6 TP73 SMAD4 MAF | 1.33e-05 | 560 | 144 | 15 | GO:0001228 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NRIP1 SUPT3H KAT6A PHF8 MED1 ARID1A JMJD1C SFMBT2 TSC22D1 YAP1 TOX3 AEBP2 CDY2A MED12 | 1.38e-05 | 562 | 144 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXO1 FOXO3 SP1 SATB2 HIVEP2 ISL1 FOXA1 MEIS1 MEIS2 USF3 PITX2 PAX6 TP73 SMAD4 MAF | 1.50e-05 | 566 | 144 | 15 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TBX22 FOXO1 FOXO3 SP1 NRIP1 SATB2 CUX2 HIVEP2 ISL1 MED1 FOXA1 MEIS1 MEIS2 HIVEP3 FOXB1 HOXB6 USF3 YAP1 PITX2 ZBTB5 TAF1 PAX6 MED12 TP73 SMAD4 MAF | 1.50e-05 | 1459 | 144 | 26 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX22 FOXO1 FOXO3 SP1 NRIP1 SATB2 CUX2 HIVEP2 ISL1 MED1 FOXA1 MEIS1 MEIS2 HIVEP3 FOXB1 HOXB6 YAP1 PITX2 PAX6 MED12 TP73 SMAD4 MAF | 2.84e-05 | 1244 | 144 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.81e-05 | 127 | 144 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX22 FOXO1 FOXO3 SP1 NRIP1 SATB2 CUX2 HIVEP2 ISL1 MED1 FOXA1 MEIS1 MEIS2 HIVEP3 FOXB1 HOXB6 YAP1 PITX2 PAX6 MED12 TP73 SMAD4 MAF | 3.97e-05 | 1271 | 144 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 6.48e-05 | 187 | 144 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 7.08e-05 | 140 | 144 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NRIP1 SUPT3H KAT6A MED1 ARID1A TSC22D1 YAP1 TOX3 MED12 | 7.15e-05 | 303 | 144 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L SP1 NRIP1 SUPT3H KAT6A PHF8 MED1 ECPAS ARID1A JMJD1C SFMBT2 TSC22D1 BAZ2A YAP1 TOX3 TNRC6A AEBP2 HTATSF1 CDY2A POLK GCN1 MED12 RBX1 | 1.06e-04 | 1356 | 144 | 23 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.12e-04 | 167 | 144 | 7 | GO:0031490 | |
| GeneOntologyMolecularFunction | NEDD8 ligase activity | 3.07e-04 | 4 | 144 | 2 | GO:0061663 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.40e-04 | 262 | 144 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 6.65e-04 | 55 | 144 | 4 | GO:0001046 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.05e-03 | 62 | 144 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | NEDD8 transferase activity | 1.06e-03 | 7 | 144 | 2 | GO:0019788 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 1.17e-03 | 29 | 144 | 3 | GO:0035035 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TBX22 FOXO1 FOXO3 SP1 SATB2 CUX2 HIVEP2 ISL1 FOXA1 MEIS1 MEIS2 HIVEP3 FOXB1 HOXB6 USF3 PITX2 ZBTB5 PAX6 TP73 SMAD4 MAF | 1.22e-03 | 1412 | 144 | 21 | GO:0000981 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF1A ZGRF1 GPN1 UPF1 ARID1A FANCM DMC1 MLH3 CCT5 ATP6V0A4 HFM1 DNAH5 | 1.67e-03 | 614 | 144 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NRIP1 SUPT3H KAT6A PHF8 MED1 ARID1A JMJD1C SFMBT2 TSC22D1 BAZ2A YAP1 TOX3 TNRC6A AEBP2 HTATSF1 CDY2A MED12 | 1.75e-03 | 1160 | 144 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.87e-03 | 34 | 144 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 2.31e-03 | 473 | 144 | 10 | GO:0004842 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.07e-03 | 83 | 144 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 3.43e-03 | 42 | 144 | 3 | GO:0051721 | |
| GeneOntologyBiologicalProcess | DNA damage response | FOXO1 FOXO3 SUPT3H ZGRF1 UPF1 MDM2 ARID1A FANCM CBL DMC1 MLH3 FAM168A WDHD1 ATXN7 YAP1 CSNK2A1 NFRKB MASTL HTATSF1 TAF1 POLK TP73 RBX1 | 2.14e-07 | 959 | 144 | 23 | GO:0006974 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO1 FOXO3 BCL9L SP1 NRIP1 SATB2 HIVEP2 ARID4B MCIDAS ISL1 PHF8 MED1 FOXA1 MEIS1 MEIS2 TSC22D1 USF3 ZNF827 ATXN7 YAP1 PITX2 TOX3 TAF1 PAX6 MED12 TP73 SMAD4 MAF | 3.21e-07 | 1390 | 144 | 28 | GO:0045944 |
| GeneOntologyBiologicalProcess | chordate embryonic development | SP1 SATB2 VEZT ISL1 SPECC1L MED1 ARID1A FOXA1 BIRC6 DSCAML1 EDNRA FOXB1 HOXB6 SLC39A12 NF1 YAP1 PITX2 PAX6 HECTD1 MED12 SMAD4 | 1.33e-06 | 906 | 144 | 21 | GO:0043009 |
| GeneOntologyBiologicalProcess | heart development | CACNA1C NEBL KAT6A ISL1 MED1 MDM2 ARID1A MEIS1 EDNRA NF1 YAP1 VWA5A PITX2 NPRL3 DNAH5 HECTD1 MED12 TP73 SMAD4 | 1.40e-06 | 757 | 144 | 19 | GO:0007507 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SP1 SATB2 VEZT ISL1 SPECC1L MED1 ARID1A FOXA1 BIRC6 DSCAML1 EDNRA FOXB1 HOXB6 SLC39A12 NF1 YAP1 PITX2 PAX6 HECTD1 MED12 SMAD4 | 1.98e-06 | 929 | 144 | 21 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryo development | CACNA1C SP1 SATB2 COL12A1 VEZT KAT6A ISL1 SPECC1L MED1 ARID1A FOXA1 BIRC6 DSCAML1 MEIS1 MEIS2 EDNRA FOXB1 HOXB6 SLC39A12 NF1 YAP1 PITX2 NFRKB PAX6 HECTD1 MED12 SMAD4 | 2.06e-06 | 1437 | 144 | 27 | GO:0009790 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | NEBL ISL1 MED1 ARID1A MEIS1 EDNRA YAP1 VWA5A PITX2 NPRL3 TP73 SMAD4 | 3.30e-06 | 327 | 144 | 12 | GO:0048738 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TBX22 FOXO1 FOXO3 NRIP1 SATB2 CUX2 ARID4B KAT6A ISL1 MED1 MDM2 ARID1A FOXA1 SFMBT2 MEIS2 ZNF827 BAZ2A YAP1 PITX2 AEBP2 ZBTB5 CDY2A TAF1 PAX6 SMAD4 MAF | 4.02e-06 | 1399 | 144 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TBX22 FOXO1 FOXO3 NRIP1 SATB2 CUX2 ARID4B KAT6A ISL1 MED1 MDM2 ARID1A FOXA1 SFMBT2 MEIS2 ZNF827 BAZ2A YAP1 PITX2 AEBP2 ZBTB5 CDY2A TAF1 PAX6 SMAD4 MAF | 4.82e-06 | 1413 | 144 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | head development | FOXO3 KIF1A KAT6A ISL1 SPECC1L PHF8 MED1 ARID1A DSCAML1 MEIS1 MEIS2 EDNRA FOXB1 NF1 PITX2 TAF1 PAX6 DNAH5 MYO16 TP73 | 6.26e-06 | 919 | 144 | 20 | GO:0060322 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | NEBL ISL1 MED1 ARID1A MEIS1 EDNRA YAP1 VWA5A PITX2 NPRL3 TP73 SMAD4 | 6.40e-06 | 349 | 144 | 12 | GO:0014706 |
| GeneOntologyBiologicalProcess | muscle tissue development | BCL9L NEBL ISL1 MED1 ARID1A MEIS1 EDNRA HIVEP3 NF1 YAP1 VWA5A PITX2 NPRL3 TP73 SMAD4 | 8.69e-06 | 558 | 144 | 15 | GO:0060537 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | CACNA1C SP1 SATB2 COL12A1 SPECC1L MED1 ARID1A DSCAML1 EDNRA HOXB6 SLC39A12 YAP1 PITX2 PAX6 HECTD1 MED12 SMAD4 | 1.03e-05 | 713 | 144 | 17 | GO:0048598 |
| GeneOntologyBiologicalProcess | DNA repair | SUPT3H ZGRF1 UPF1 ARID1A FANCM DMC1 MLH3 FAM168A WDHD1 ATXN7 CSNK2A1 NFRKB HTATSF1 POLK TP73 RBX1 | 1.24e-05 | 648 | 144 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | neural tube development | 1.26e-05 | 202 | 144 | 9 | GO:0021915 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TBX22 FOXO1 FOXO3 NRIP1 SATB2 CUX2 ARID4B ISL1 MED1 MDM2 ARID1A FOXA1 MEIS2 YAP1 PITX2 AEBP2 ZBTB5 TAF1 PAX6 SMAD4 MAF | 1.36e-05 | 1053 | 144 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.77e-05 | 161 | 144 | 8 | GO:0003231 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.85e-05 | 212 | 144 | 9 | GO:0003205 | |
| GeneOntologyBiologicalProcess | pattern specification process | SATB2 ISL1 FOXA1 DSCAML1 MEIS1 MEIS2 EDNRA FOXB1 HOXB6 PITX2 PAX6 DNAH5 MED12 SMAD4 | 1.97e-05 | 526 | 144 | 14 | GO:0007389 |
| GeneOntologyBiologicalProcess | embryonic organ development | SP1 SATB2 KAT6A MED1 ARID1A BIRC6 DSCAML1 EDNRA HOXB6 YAP1 PITX2 PAX6 HECTD1 MED12 | 3.98e-05 | 561 | 144 | 14 | GO:0048568 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 4.44e-05 | 237 | 144 | 9 | GO:0019827 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 5.13e-05 | 94 | 144 | 6 | GO:0045665 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 5.22e-05 | 242 | 144 | 9 | GO:0098727 | |
| GeneOntologyBiologicalProcess | circulatory system development | FOXO1 CACNA1C SP1 MIA3 NEBL KAT6A ISL1 MED1 MDM2 ARID1A MEIS1 EDNRA SLC39A12 NF1 YAP1 VWA5A PITX2 NPRL3 PAX6 DNAH5 HECTD1 MED12 TP73 SMAD4 | 5.97e-05 | 1442 | 144 | 24 | GO:0072359 |
| GeneOntologyBiologicalProcess | DNA metabolic process | SUPT3H MCIDAS ZGRF1 UPF1 ARID1A FANCM DMC1 MLH3 FAM168A WDHD1 CCT5 ZNF827 ATXN7 CSNK2A1 NFRKB HTATSF1 HFM1 POLK TP73 RBX1 | 6.38e-05 | 1081 | 144 | 20 | GO:0006259 |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 7.81e-05 | 255 | 144 | 9 | GO:0045664 | |
| GeneOntologyBiologicalProcess | brain development | FOXO3 KIF1A ISL1 PHF8 MED1 ARID1A DSCAML1 MEIS1 MEIS2 FOXB1 NF1 PITX2 TAF1 PAX6 DNAH5 MYO16 TP73 | 1.06e-04 | 859 | 144 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | response to water-immersion restraint stress | 1.45e-04 | 3 | 144 | 2 | GO:1990785 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 1.65e-04 | 221 | 144 | 8 | GO:0035051 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.83e-04 | 351 | 144 | 10 | GO:0048562 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | SPECC1L MED1 ARID1A FOXA1 EDNRA SLC39A12 YAP1 PITX2 HECTD1 MED12 SMAD4 | 1.85e-04 | 421 | 144 | 11 | GO:0060562 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | AMBN FOXO3 SP1 SATB2 KAT6A ISL1 MED1 MDM2 ARID1A FOXA1 DSCAML1 MEIS1 MEIS2 EDNRA HOXB6 NF1 YAP1 PITX2 PAX6 MED12 SMAD4 | 1.97e-04 | 1269 | 144 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 2.04e-04 | 77 | 144 | 5 | GO:0055008 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SATB2 ARID4B KAT6A PHF8 MED1 ARID1A FOXA1 JMJD1C DMC1 WDHD1 ZNF827 BAZ2A NFRKB AEBP2 HTATSF1 CDY2A TAF1 PAX6 | 2.11e-04 | 999 | 144 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 2.17e-04 | 78 | 144 | 5 | GO:0051865 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 2.49e-04 | 177 | 144 | 7 | GO:0055007 | |
| GeneOntologyBiologicalProcess | blood vessel development | FOXO1 SP1 MIA3 KAT6A ISL1 MED1 MDM2 ARID1A MEIS1 EDNRA SLC39A12 NF1 YAP1 PITX2 NPRL3 PAX6 HECTD1 | 2.68e-04 | 929 | 144 | 17 | GO:0001568 |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 2.72e-04 | 45 | 144 | 4 | GO:0031076 | |
| GeneOntologyBiologicalProcess | tube development | SP1 MIA3 KAT6A ISL1 SPECC1L MED1 ARID1A FOXA1 JMJD1C MEIS1 EDNRA FOXB1 SLC39A12 NF1 YAP1 PITX2 NPRL3 PAX6 HECTD1 MED12 TP73 SMAD4 | 2.89e-04 | 1402 | 144 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.91e-04 | 372 | 144 | 10 | GO:0060485 | |
| GeneOntologyBiologicalProcess | regulation of hydrogen peroxide-mediated programmed cell death | 2.98e-04 | 19 | 144 | 3 | GO:1901298 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | SP1 MIA3 KAT6A ISL1 SPECC1L MED1 ARID1A FOXA1 MEIS1 EDNRA SLC39A12 NF1 YAP1 PITX2 NPRL3 HECTD1 MED12 TP73 SMAD4 | 3.17e-04 | 1125 | 144 | 19 | GO:0035239 |
| GeneOntologyBiologicalProcess | muscle structure development | DOCK2 BCL9L NEBL ISL1 MED1 MDM2 ARID1A MEIS1 EDNRA SMTN HIVEP3 NF1 VWA5A PITX2 MBNL3 SMAD4 | 3.32e-04 | 858 | 144 | 16 | GO:0061061 |
| GeneOntologyBiologicalProcess | cardiac septum development | 3.60e-04 | 134 | 144 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | vasculature development | FOXO1 SP1 MIA3 KAT6A ISL1 MED1 MDM2 ARID1A MEIS1 EDNRA SLC39A12 NF1 YAP1 PITX2 NPRL3 PAX6 HECTD1 | 4.35e-04 | 969 | 144 | 17 | GO:0001944 |
| GeneOntologyBiologicalProcess | ventricular septum development | 4.44e-04 | 91 | 144 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 4.44e-04 | 91 | 144 | 5 | GO:0009880 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide-mediated programmed cell death | 4.66e-04 | 22 | 144 | 3 | GO:0010421 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 4.91e-04 | 93 | 144 | 5 | GO:0060415 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 5.18e-04 | 262 | 144 | 8 | GO:0031669 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in heart morphogenesis | 5.33e-04 | 23 | 144 | 3 | GO:0061323 | |
| GeneOntologyBiologicalProcess | chromatin organization | SATB2 ARID4B KAT6A PHF8 ARID1A FOXA1 JMJD1C WDHD1 ZNF827 BAZ2A NFRKB AEBP2 HTATSF1 CDY2A TAF1 PAX6 | 5.34e-04 | 896 | 144 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | regionalization | ISL1 FOXA1 DSCAML1 EDNRA FOXB1 HOXB6 PITX2 PAX6 DNAH5 MED12 SMAD4 | 5.43e-04 | 478 | 144 | 11 | GO:0003002 |
| GeneOntologyBiologicalProcess | programmed cell death in response to reactive oxygen species | 6.06e-04 | 24 | 144 | 3 | GO:0097468 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 6.10e-04 | 148 | 144 | 6 | GO:0048706 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | BCL9L CUX2 KIF1A MYCBP2 DOCK10 ISL1 MED1 DSCAML1 JMJD1C EDNRA FOXB1 SLC39A12 CDH22 DST YAP1 PAX6 CAMSAP1 MYO16 SMAD4 | 6.57e-04 | 1194 | 144 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 6.75e-04 | 57 | 144 | 4 | GO:0030520 | |
| GeneOntologyBiologicalProcess | central nervous system development | FOXO3 KIF1A MYCBP2 ISL1 PHF8 MED1 ARID1A DSCAML1 MEIS1 MEIS2 FOXB1 NF1 PITX2 TAF1 PAX6 DNAH5 MED12 MYO16 TP73 | 6.77e-04 | 1197 | 144 | 19 | GO:0007417 |
| GeneOntologyBiologicalProcess | sensory system development | 6.78e-04 | 491 | 144 | 11 | GO:0048880 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue development | 6.85e-04 | 25 | 144 | 3 | GO:0003228 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | SATB2 ARID4B KAT6A PHF8 ARID1A FOXA1 JMJD1C WDHD1 ZNF827 BAZ2A NFRKB CDY2A TAF1 PAX6 | 6.99e-04 | 741 | 144 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of protein autoubiquitination | 7.13e-04 | 6 | 144 | 2 | GO:1902498 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 7.49e-04 | 102 | 144 | 5 | GO:0048644 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 7.70e-04 | 59 | 144 | 4 | GO:0055010 | |
| GeneOntologyBiologicalProcess | neural crest cell differentiation | 8.17e-04 | 104 | 144 | 5 | GO:0014033 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 8.73e-04 | 61 | 144 | 4 | GO:1902895 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 9.28e-04 | 62 | 144 | 4 | GO:0001755 | |
| GeneOntologyBiologicalProcess | endocrine system development | 9.47e-04 | 161 | 144 | 6 | GO:0035270 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 9.47e-04 | 161 | 144 | 6 | GO:0003206 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 9.81e-04 | 289 | 144 | 8 | GO:0000209 | |
| GeneOntologyBiologicalProcess | female gamete generation | 9.88e-04 | 223 | 144 | 7 | GO:0007292 | |
| GeneOntologyBiologicalProcess | formation of anatomical boundary | 9.93e-04 | 7 | 144 | 2 | GO:0048859 | |
| GeneOntologyBiologicalProcess | left ventricular cardiac muscle tissue morphogenesis | 9.93e-04 | 7 | 144 | 2 | GO:0003220 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 9.93e-04 | 7 | 144 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | FOXO1 FOXO3 BCL9L ISL1 EDNRA YAP1 CSNK2A1 PITX2 MED12 SMAD4 RBX1 | 1.01e-03 | 516 | 144 | 11 | GO:0016055 |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 1.05e-03 | 64 | 144 | 4 | GO:0090497 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.14e-03 | 296 | 144 | 8 | GO:0048762 | |
| GeneOntologyBiologicalProcess | response to starvation | 1.15e-03 | 229 | 144 | 7 | GO:0042594 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | FOXO1 FOXO3 ISL1 MED1 FOXA1 MEIS1 MEIS2 TSC22D1 USF3 NF1 YAP1 PAX6 MBNL3 TP73 SMAD4 | 1.21e-03 | 875 | 144 | 15 | GO:0045596 |
| GeneOntologyBiologicalProcess | reciprocal meiotic recombination | 1.24e-03 | 67 | 144 | 4 | GO:0007131 | |
| GeneOntologyBiologicalProcess | reciprocal homologous recombination | 1.24e-03 | 67 | 144 | 4 | GO:0140527 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.29e-03 | 171 | 144 | 6 | GO:0048593 | |
| GeneOntologyCellularComponent | chromatin | TBX22 FOXO1 FOXO3 SP1 NRIP1 SUPT3H SATB2 CUX2 ARID4B KAT6A ISL1 UPF1 MED1 ARID1A FOXA1 FANCM JMJD1C MEIS1 MEIS2 FOXB1 HOXB6 ZNF827 BAZ2A ATXN7 CSNK2A1 PITX2 NFRKB AEBP2 ZBTB5 TAF1 PAX6 TP73 SMAD4 MAF | 4.64e-10 | 1480 | 146 | 34 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | FOXO3 BCL9L SP1 SUPT3H SATB2 HIVEP2 ISL1 MED1 MDM2 MEIS1 ATXN7 YAP1 PITX2 TAF1 PAX6 SMAD4 MAF | 9.52e-07 | 596 | 146 | 17 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FOXO3 BCL9L NRIP1 SUPT3H SATB2 ARID4B PTBP2 UPF1 MED1 ARID1A FANCM JMJD1C ZC3H11A BAZ2A ATXN7 YAP1 CSNK2A1 NFRKB AEBP2 HTATSF1 TAF1 MED12 SMAD4 RBX1 MAF | 9.71e-06 | 1377 | 146 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.25e-04 | 85 | 146 | 5 | GO:0000118 | |
| HumanPheno | Thin vermilion border | CACNA1C SATB2 HIVEP2 KAT6A SPECC1L ARID1A MEIS2 NF1 CSNK2A1 PITX2 TAF1 MBD5 MED12 SMAD4 SON MAF | 1.58e-05 | 433 | 58 | 16 | HP:0000233 |
| HumanPheno | Thin upper lip vermilion | CACNA1C SATB2 HIVEP2 KAT6A SPECC1L ARID1A MEIS2 CSNK2A1 PITX2 TAF1 MBD5 MED12 SMAD4 MAF | 1.76e-05 | 339 | 58 | 14 | HP:0000219 |
| HumanPheno | Thin lips | CACNA1C SATB2 HIVEP2 KAT6A SPECC1L ARID1A MEIS2 CSNK2A1 PITX2 TAF1 MBD5 MED12 SMAD4 MAF | 1.76e-05 | 339 | 58 | 14 | HP:0000213 |
| MousePheno | abnormal head morphology | TBX22 AMBN CCP110 SATB2 MIA3 PTBP2 DDR2 KAT6A ISL1 SPECC1L MED1 MDM2 CBL EDNRA RGL1 DST NF1 MIGA2 CSNK2A1 PITX2 NPRL3 PAX6 MBD5 DNAH5 HECTD1 GCN1 MED12 TP73 SON MAF | 2.41e-08 | 1120 | 123 | 30 | MP:0000432 |
| MousePheno | abnormal craniofacial morphology | TBX22 AMBN FOXO1 CCP110 SATB2 MIA3 PTBP2 DDR2 KAT6A ISL1 SPECC1L MDM2 CBL SFMBT2 EDNRA RGL1 DST NF1 MIGA2 CSNK2A1 PITX2 NPRL3 PAX6 MBD5 DNAH5 HECTD1 GCN1 MED12 TP73 MAF | 1.97e-06 | 1372 | 123 | 30 | MP:0000428 |
| MousePheno | craniofacial phenotype | TBX22 AMBN FOXO1 CCP110 SATB2 MIA3 PTBP2 DDR2 KAT6A ISL1 SPECC1L MDM2 CBL SFMBT2 EDNRA RGL1 DST NF1 MIGA2 CSNK2A1 PITX2 NPRL3 PAX6 MBD5 DNAH5 HECTD1 GCN1 MED12 TP73 MAF | 1.97e-06 | 1372 | 123 | 30 | MP:0005382 |
| MousePheno | perinatal lethality | TBX22 CACNA1C CCP110 SATB2 MIA3 COL12A1 KIF1A MYCBP2 PTBP2 UBR4 KAT6A ISL1 SPECC1L ARID1A CBL BIRC6 EDNRA FOXB1 PITX2 PAX6 CAMSAP1 MBD5 DNAH5 HECTD1 GCN1 MAF | 4.47e-06 | 1130 | 123 | 26 | MP:0002081 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | CACNA1C CCP110 SUPT3H SATB2 MIA3 KIF1A MYCBP2 PTBP2 UBR4 KAT6A ISL1 SPECC1L ARID1A FOXA1 BIRC6 MEIS1 MEIS2 EDNRA DST NF1 PITX2 NPRL3 PAX6 MBD5 HECTD1 GCN1 MAF | 1.20e-05 | 1269 | 123 | 27 | MP:0011111 |
| MousePheno | abnormal facial morphology | TBX22 AMBN CCP110 SATB2 MIA3 PTBP2 DDR2 KAT6A SPECC1L MDM2 EDNRA RGL1 DST NF1 MIGA2 CSNK2A1 PITX2 NPRL3 PAX6 MBD5 DNAH5 TP73 | 1.29e-05 | 910 | 123 | 22 | MP:0003743 |
| MousePheno | abnormal pharyngeal arch morphology | 1.98e-05 | 171 | 123 | 9 | MP:0002884 | |
| MousePheno | abnormal craniofacial development | AMBN FOXO1 CCP110 SATB2 KAT6A ISL1 SPECC1L SFMBT2 EDNRA CSNK2A1 PITX2 PAX6 HECTD1 MED12 | 2.19e-05 | 425 | 123 | 14 | MP:0003935 |
| MousePheno | abnormal mouth morphology | TBX22 AMBN CCP110 SATB2 PTBP2 KAT6A SPECC1L MDM2 EDNRA RGL1 DST NF1 MIGA2 CSNK2A1 PITX2 NPRL3 PAX6 MBD5 | 2.21e-05 | 670 | 123 | 18 | MP:0000452 |
| MousePheno | abnormal nervous system development | CCP110 CUX2 MYCBP2 PTBP2 MCIDAS ISL1 SPECC1L MED1 ARID1A SFMBT2 PTPRT RGL1 FOXB1 ZC3H11A NF1 CSNK2A1 PCDH19 PITX2 PAX6 CAMSAP1 SRRM3 DNAH5 HECTD1 GCN1 MED12 TP73 | 2.95e-05 | 1257 | 123 | 26 | MP:0003861 |
| MousePheno | abnormal embryonic tissue morphology | FOXO1 CACNA1C CCP110 SP1 SATB2 CUX2 KAT6A ISL1 SPECC1L MED1 MDM2 ARID1A SFMBT2 EDNRA RGL1 FOXB1 ZC3H11A NF1 YAP1 CSNK2A1 PITX2 HECTD1 MED12 SMAD4 | 3.41e-05 | 1116 | 123 | 24 | MP:0002085 |
| MousePheno | abnormal prenatal body size | BCL9L CCP110 SP1 MIA3 UBR4 KAT6A ISL1 MED1 MDM2 ARID1A BIRC6 MEIS2 FOXB1 DST WDHD1 PAPOLA CCT5 YAP1 PITX2 NPRL3 PAX6 GCN1 SMAD4 RBX1 | 3.41e-05 | 1116 | 123 | 24 | MP:0010866 |
| MousePheno | perinatal lethality, complete penetrance | CACNA1C CCP110 SATB2 MIA3 MYCBP2 PTBP2 UBR4 KAT6A ISL1 SPECC1L ARID1A BIRC6 EDNRA PITX2 PAX6 HECTD1 GCN1 MAF | 4.92e-05 | 712 | 123 | 18 | MP:0011089 |
| MousePheno | abnormal cardiovascular development | FOXO1 CACNA1C CCP110 UBR4 KAT6A ISL1 MED1 ARID1A BIRC6 MEIS1 MEIS2 EDNRA NF1 YAP1 CSNK2A1 PITX2 NPRL3 DNAH5 MED12 | 7.15e-05 | 802 | 123 | 19 | MP:0002925 |
| MousePheno | abnormal prenatal growth/weight/body size | FOXO1 BCL9L CCP110 SP1 MIA3 UBR4 KAT6A ISL1 MED1 MDM2 ARID1A BIRC6 SFMBT2 MEIS2 RGL1 FOXB1 DST WDHD1 PAPOLA CCT5 YAP1 PITX2 NPRL3 PAX6 GCN1 SMAD4 RBX1 MAF | 7.94e-05 | 1493 | 123 | 28 | MP:0004196 |
| MousePheno | abnormal heart and great artery attachment | 8.19e-05 | 205 | 123 | 9 | MP:0010426 | |
| MousePheno | digestive/alimentary phenotype | TBX22 ESPN FOXO3 CCP110 NRIP1 SATB2 KAT6A ISL1 SPECC1L SLC34A3 MDM2 PTPRT EDNRA SMTN RGL1 DST NF1 YAP1 PITX2 AEBP2 NPRL3 OR1E2 PAX6 PAN3 DNAH5 IL17RB TP73 SMAD4 | 8.62e-05 | 1500 | 123 | 28 | MP:0005381 |
| MousePheno | abnormal heart and great vessel attachment | 9.15e-05 | 208 | 123 | 9 | MP:0010425 | |
| MousePheno | ventricular septal defect | CCP110 KAT6A ARID1A MEIS1 EDNRA NF1 PITX2 NPRL3 DNAH5 HECTD1 | 1.02e-04 | 261 | 123 | 10 | MP:0010402 |
| MousePheno | abnormal second pharyngeal arch morphology | 1.14e-04 | 29 | 123 | 4 | MP:0006338 | |
| MousePheno | abnormal cornea endothelium morphology | 1.78e-04 | 13 | 123 | 3 | MP:0005301 | |
| MousePheno | small second pharyngeal arch | 1.78e-04 | 13 | 123 | 3 | MP:0006344 | |
| MousePheno | abnormal cell cycle | TPP2 CCP110 CUX2 MED1 MDM2 FANCM BIRC6 DMC1 MLH3 MASTL HFM1 GCN1 TP73 RBX1 | 1.90e-04 | 520 | 123 | 14 | MP:0003077 |
| MousePheno | abnormal diencephalon morphology | 2.99e-04 | 298 | 123 | 10 | MP:0000830 | |
| MousePheno | abnormal embryo development | FOXO1 BCL9L CCP110 VEZT UBR4 GPN1 ISL1 UPF1 MED1 MDM2 ARID1A SFMBT2 MEIS2 RGL1 FOXB1 WDHD1 CCT5 YAP1 PITX2 GCN1 MED12 TP73 SMAD4 RBX1 MAF | 3.18e-04 | 1370 | 123 | 25 | MP:0001672 |
| MousePheno | abnormal forebrain morphology | FOXO3 CACNA1C CUX2 HIVEP2 MYCBP2 PTBP2 MCIDAS DDR2 ISL1 PHF8 MED1 ARID1A FOXB1 CSNK2A1 PCDH19 PITX2 PAX6 CAMSAP1 MBD5 DNAH5 TP73 | 4.10e-04 | 1072 | 123 | 21 | MP:0000783 |
| MousePheno | abnormal digestive system morphology | TBX22 CCP110 NRIP1 SATB2 KAT6A ISL1 SPECC1L MDM2 PTPRT EDNRA SMTN RGL1 DST NF1 PITX2 AEBP2 NPRL3 OR1E2 PAX6 PAN3 DNAH5 TP73 SMAD4 | 4.22e-04 | 1233 | 123 | 23 | MP:0000462 |
| MousePheno | lethality throughout fetal growth and development | CACNA1C SUPT3H KAT6A CBL BIRC6 MEIS1 MEIS2 FOXB1 NF1 PITX2 NPRL3 MAF | 4.50e-04 | 435 | 123 | 12 | MP:0006208 |
| MousePheno | small liver | 4.64e-04 | 315 | 123 | 10 | MP:0000601 | |
| MousePheno | abnormal eye size | AMBN SFMBT2 MEIS1 EDNRA MS4A4A RGL1 NF1 PITX2 PAX6 HECTD1 MAF | 4.70e-04 | 375 | 123 | 11 | MP:0002697 |
| MousePheno | failure of superovulation | 4.93e-04 | 18 | 123 | 3 | MP:0031422 | |
| MousePheno | abnormal palate morphology | TBX22 CCP110 SATB2 KAT6A SPECC1L EDNRA RGL1 PITX2 NPRL3 PAX6 | 5.37e-04 | 321 | 123 | 10 | MP:0003755 |
| MousePheno | interrupted aorta | 5.40e-04 | 43 | 123 | 4 | MP:0010544 | |
| MousePheno | abnormal heart ventricle morphology | CACNA1C CCP110 KAT6A ISL1 PHF8 MED1 ARID1A CBL MEIS1 EDNRA SMTN NF1 CSNK2A1 PITX2 NPRL3 DNAH5 HECTD1 | 5.69e-04 | 793 | 123 | 17 | MP:0005294 |
| Domain | ARM-like | 4.46e-05 | 270 | 143 | 10 | IPR011989 | |
| Domain | FOXO_KIX-bd | 5.82e-05 | 2 | 143 | 2 | IPR032068 | |
| Domain | Ecm29/Gcn1 | 5.82e-05 | 2 | 143 | 2 | IPR026827 | |
| Domain | FOXO_KIX_bdg | 5.82e-05 | 2 | 143 | 2 | PF16675 | |
| Domain | FOXO-TAD | 1.74e-04 | 3 | 143 | 2 | IPR032067 | |
| Domain | FOXO-TAD | 1.74e-04 | 3 | 143 | 2 | PF16676 | |
| Domain | CH | 2.43e-04 | 73 | 143 | 5 | PS50021 | |
| Domain | CH-domain | 2.75e-04 | 75 | 143 | 5 | IPR001715 | |
| Domain | - | 3.16e-04 | 222 | 143 | 8 | 1.25.10.10 | |
| Domain | - | 3.37e-04 | 283 | 143 | 9 | 1.10.10.60 | |
| Domain | TF_fork_head_CS_2 | 4.19e-04 | 46 | 143 | 4 | IPR030456 | |
| Domain | Homeobox | 4.49e-04 | 234 | 143 | 8 | PF00046 | |
| Domain | TF_fork_head_CS_1 | 4.55e-04 | 47 | 143 | 4 | IPR018122 | |
| Domain | HOMEOBOX_1 | 4.75e-04 | 236 | 143 | 8 | PS00027 | |
| Domain | HOX | 4.88e-04 | 237 | 143 | 8 | SM00389 | |
| Domain | HOMEOBOX_2 | 5.16e-04 | 239 | 143 | 8 | PS50071 | |
| Domain | Homeobox_dom | 5.16e-04 | 239 | 143 | 8 | IPR001356 | |
| Domain | FH | 5.34e-04 | 49 | 143 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 5.34e-04 | 49 | 143 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 5.34e-04 | 49 | 143 | 4 | PS00658 | |
| Domain | Fork_head_dom | 5.34e-04 | 49 | 143 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 5.34e-04 | 49 | 143 | 4 | PS50039 | |
| Domain | Forkhead | 5.34e-04 | 49 | 143 | 4 | PF00250 | |
| Domain | PKNOX/Meis_N | 5.73e-04 | 5 | 143 | 2 | IPR032453 | |
| Domain | Meis_PKNOX_N | 5.73e-04 | 5 | 143 | 2 | PF16493 | |
| Domain | Homeodomain-like | 1.05e-03 | 332 | 143 | 9 | IPR009057 | |
| Domain | CUT | 1.19e-03 | 7 | 143 | 2 | PS51042 | |
| Domain | CUT | 1.19e-03 | 7 | 143 | 2 | PF02376 | |
| Domain | CUT_dom | 1.19e-03 | 7 | 143 | 2 | IPR003350 | |
| Domain | CUT | 1.19e-03 | 7 | 143 | 2 | SM01109 | |
| Domain | ARM-type_fold | 1.22e-03 | 339 | 143 | 9 | IPR016024 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 2.39e-06 | 153 | 107 | 9 | M39546 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.46e-05 | 7 | 107 | 3 | MM15661 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 8.43e-05 | 31 | 107 | 4 | M27805 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.32e-04 | 65 | 107 | 5 | M39682 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.22e-04 | 16 | 107 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.68e-04 | 17 | 107 | 3 | M27412 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 2.68e-04 | 17 | 107 | 3 | M27946 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 2.88e-04 | 119 | 107 | 6 | M27785 | |
| Pathway | PID_P73PATHWAY | 3.31e-04 | 79 | 107 | 5 | M19 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 4.16e-04 | 83 | 107 | 5 | M39637 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.12e-04 | 21 | 107 | 3 | MM15706 | |
| Pathway | REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION | 5.62e-04 | 5 | 107 | 2 | M27825 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 5.89e-04 | 22 | 107 | 3 | MM15656 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | FOXO1 FOXO3 SP1 SATB2 KAT6A MAMLD1 MED1 MDM2 ARID1A HIVEP3 ZC3H11A PAPOLA YAP1 CSNK2A1 PITX2 TNRC6A TAF1 MED12 TP73 SMAD4 RBX1 MAF | 6.34e-04 | 1387 | 107 | 22 | M734 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | FOXO1 FOXO3 SP1 KAT6A MAMLD1 MED1 MDM2 ARID1A ZC3H11A PAPOLA YAP1 CSNK2A1 TNRC6A AEBP2 TAF1 TP73 SMAD4 RBX1 | 6.44e-04 | 1022 | 107 | 18 | MM15436 |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.74e-04 | 23 | 107 | 3 | M556 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 6.90e-04 | 53 | 107 | 4 | M39349 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 7.38e-04 | 142 | 107 | 6 | M39575 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 7.65e-04 | 143 | 107 | 6 | M39591 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 7.66e-04 | 24 | 107 | 3 | M27803 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 7.95e-04 | 55 | 107 | 4 | M39598 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 8.11e-04 | 96 | 107 | 5 | M27784 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 8.39e-04 | 6 | 107 | 2 | MM15660 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 8.39e-04 | 6 | 107 | 2 | MM14517 | |
| Pathway | REACTOME_DEUBIQUITINATION | 8.54e-04 | 262 | 107 | 8 | MM15286 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 9.73e-04 | 26 | 107 | 3 | M27558 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 9.73e-04 | 26 | 107 | 3 | M27483 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN FOXO3 CACNA1C NRIP1 MIA3 HIVEP2 KIF1A MYCBP2 VEZT PTBP2 KAT6A RALGAPB ECPAS ARID1A JMJD1C SFMBT2 PLEKHH1 HIVEP3 TSC22D1 HOXB6 ZC3H11A USF3 PTPN13 FAM168A ZNF827 ATXN7 TOX3 LIMCH1 PAN3 MBD5 POLK HECTD1 MAF | 3.41e-15 | 1489 | 147 | 33 | 28611215 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX22 FOXO1 FOXO3 SP1 SATB2 CUX2 HIVEP2 ISL1 FOXA1 MEIS1 MEIS2 HIVEP3 FOXB1 TSC22D1 HOXB6 ZC3H11A USF3 WDHD1 PITX2 TOX3 PAX6 MBNL3 TP73 SMAD4 MAF | 1.05e-13 | 908 | 147 | 25 | 19274049 |
| Pubmed | NRIP1 SATB2 MYCBP2 ZGRF1 UBR4 ECPAS BIRC6 JMJD1C SFMBT2 PTPN13 DST TNRC6A TAF1 CAMSAP1 PC GCN1 MED12 S100PBP | 2.50e-13 | 418 | 147 | 18 | 34709266 | |
| Pubmed | MYCBP2 SPECC1L UPF1 PHF8 MED1 ARID1A CBL JMJD1C ZC3H11A PTPN13 CCT5 BAZ2A YAP1 NFRKB TAF1 PC GCN1 MED12 | 2.33e-11 | 549 | 147 | 18 | 38280479 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SMAP1 SATB2 GPN1 MAMLD1 UPF1 MED1 JMJD1C SMTN ZC3H11A ATXN7 VWA5A NFRKB MASTL ZBTB5 POLK PC | 8.06e-11 | 444 | 147 | 16 | 34795231 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 AFTPH ARID4B MYCBP2 RALGAPB PHF8 MED1 ECPAS SMTN ZC3H11A NF1 WDHD1 PAPOLA BAZ2A ATXN7 YAP1 CSNK2A1 NFRKB LIMCH1 SON | 1.16e-10 | 774 | 147 | 20 | 15302935 |
| Pubmed | FOXO1 FOXO3 SP1 SATB2 CUX2 PHF8 ARID1A MEIS1 MEIS2 HIVEP3 TSC22D1 HOXB6 BAZ2A PITX2 TOX3 AEBP2 ZBTB5 PAX6 MBNL3 SMAD4 | 2.46e-10 | 808 | 147 | 20 | 20412781 | |
| Pubmed | TPP2 KIF1A MYCBP2 UBR4 UPF1 ECPAS ARID1A BIRC6 ZC3H11A DST NF1 CCT5 BAZ2A CSNK2A1 HECTD1 GCN1 MED12 SON | 3.82e-10 | 653 | 147 | 18 | 22586326 | |
| Pubmed | FOXO3 BCL9L CCP110 MIA3 RALGAPB ECPAS ARID1A CBL BIRC6 PTPN13 DST NF1 YAP1 TNRC6A HECTD1 | 8.34e-10 | 446 | 147 | 15 | 24255178 | |
| Pubmed | MON2 AMBN SUPT3H ARID4B VEZT KAT6A PHF8 MDM2 ARID1A FOXA1 MLH3 ZNF827 BAZ2A ATXN7 CSNK2A1 PCDH19 RTL9 NFRKB TNRC6A TAF1 TP73 SON | 2.03e-09 | 1116 | 147 | 22 | 31753913 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO1 FOXO3 SATB2 ARID4B UBR4 ISL1 ECPAS MDM2 FOXA1 JMJD1C MEIS1 FOXB1 ZC3H11A WDHD1 A2ML1 PITX2 CAMSAP1 SMAD4 | 2.61e-08 | 857 | 147 | 18 | 25609649 |
| Pubmed | MON2 FOXO3 SP1 ARID4B UBR4 RALGAPB UPF1 SLC34A3 MED1 BIRC6 MEIS2 ZC3H11A NF1 CCT5 CSNK2A1 NFRKB AEBP2 PC HECTD1 GCN1 MED12 RBX1 | 4.51e-08 | 1327 | 147 | 22 | 32694731 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 18216174 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 18548200 | ||
| Pubmed | MON2 CCP110 MIA3 NEBL MYCBP2 VEZT UBAP1 BIRC6 JMJD1C WDHD1 YAP1 NFRKB TNRC6A MASTL CAMSAP1 HECTD1 | 9.72e-08 | 733 | 147 | 16 | 34672954 | |
| Pubmed | MON2 TPP2 MIA3 HIVEP2 UBR4 MAMLD1 ZC3H11A PTPN13 DST CCT5 HECTD1 | 1.40e-07 | 322 | 147 | 11 | 26514267 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 FOXO3 CCP110 HIVEP2 AFTPH MYCBP2 RALGAPB CBL PTPN13 DST NF1 YAP1 LIMCH1 PAN3 CAMSAP1 PC HECTD1 | 1.57e-07 | 861 | 147 | 17 | 36931259 |
| Pubmed | BCL9L SP1 SUPT3H SATB2 ARID4B UBR4 UPF1 PHF8 MDM2 ARID1A FOXA1 JMJD1C DST CCT5 ATXN7 YAP1 CSNK2A1 NFRKB TNRC6A TAF1 PAX6 PAN3 | 1.62e-07 | 1429 | 147 | 22 | 35140242 | |
| Pubmed | SP1 HIVEP2 ARID4B SPECC1L CBL RGL1 TSC22D1 USF3 DST TNRC6A TAF1 MBD5 GCN1 | 1.68e-07 | 486 | 147 | 13 | 20936779 | |
| Pubmed | DOCK2 CCP110 PAIP2B FANCM BIRC6 JMJD1C HIVEP3 RGL1 TSC22D1 USF3 MBD5 HECTD1 MED12 | 1.98e-07 | 493 | 147 | 13 | 15368895 | |
| Pubmed | Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development. | 2.13e-07 | 13 | 147 | 4 | 17049510 | |
| Pubmed | BCL9L MED1 ARID1A FOXA1 JMJD1C YAP1 CSNK2A1 NFRKB TAF1 MED12 | 2.35e-07 | 268 | 147 | 10 | 33640491 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 FOXO3 HIVEP2 MYCBP2 UBR4 KAT6A ARID1A BIRC6 HIVEP3 ZC3H11A DST ZNF827 NPRL3 CAMSAP1 MBD5 PC HECTD1 GCN1 MED12 | 2.35e-07 | 1105 | 147 | 19 | 35748872 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UBR4 PHF8 MED1 ECPAS ARID1A JMJD1C WDHD1 PAPOLA BAZ2A YAP1 MED12 | 2.48e-07 | 341 | 147 | 11 | 32971831 |
| Pubmed | MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. | 2.95e-07 | 4 | 147 | 3 | 19321440 | |
| Pubmed | FOXO1 SP1 CUX2 HIVEP2 KIF1A ISL1 ARID1A FOXA1 CBL BIRC6 MEIS1 MEIS2 BAZ2A PITX2 PAX6 | 3.71e-07 | 709 | 147 | 15 | 22988430 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 3.78e-07 | 157 | 147 | 8 | 30686591 | |
| Pubmed | 5.36e-07 | 16 | 147 | 4 | 16376864 | ||
| Pubmed | Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development. | 5.36e-07 | 16 | 147 | 4 | 35379703 | |
| Pubmed | 5.37e-07 | 225 | 147 | 9 | 12168954 | ||
| Pubmed | SP1 NRIP1 SATB2 ARID4B UBR4 MUC16 MED1 ARID1A CBL PLEKHH1 NF1 WDHD1 ATXN7 HFM1 | 6.03e-07 | 638 | 147 | 14 | 31182584 | |
| Pubmed | Understanding the development of oral epithelial organs through single cell transcriptomic analysis. | 6.94e-07 | 73 | 147 | 6 | 35831953 | |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 22511764 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 18616618 | ||
| Pubmed | Meis1 coordinates a network of genes implicated in eye development and microphthalmia. | 8.95e-07 | 18 | 147 | 4 | 26253404 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SP1 NRIP1 HIVEP2 ISL1 MED1 FOXA1 MEIS1 MEIS2 FOXB1 HOXB6 PITX2 TOX3 ZBTB5 PAX6 TP73 SMAD4 | 1.05e-06 | 877 | 147 | 16 | 20211142 |
| Pubmed | MON2 RALGAPB DOCK10 PHF8 PLEKHH1 ZC3H11A FAM168A BAZ2A PCDH19 LIMCH1 SON | 1.40e-06 | 407 | 147 | 11 | 12693553 | |
| Pubmed | STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | 1.41e-06 | 20 | 147 | 4 | 17967894 | |
| Pubmed | 1.43e-06 | 130 | 147 | 7 | 19386638 | ||
| Pubmed | 1.47e-06 | 6 | 147 | 3 | 24899714 | ||
| Pubmed | The emergent landscape of the mouse gut endoderm at single-cell resolution. | 1.86e-06 | 48 | 147 | 5 | 30959515 | |
| Pubmed | 1.96e-06 | 263 | 147 | 9 | 20932939 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.39e-06 | 430 | 147 | 11 | 35044719 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 SUPT3H ARID4B PHF8 MED1 ARID1A FANCM JMJD1C ZC3H11A DST BAZ2A YAP1 NFRKB HTATSF1 PAX6 PC SMAD4 RBX1 SON | 2.46e-06 | 1294 | 147 | 19 | 30804502 |
| Pubmed | Precise temporal control of the eye regulatory gene Pax6 via enhancer-binding site affinity. | 2.56e-06 | 7 | 147 | 3 | 20413611 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.61e-06 | 203 | 147 | 8 | 22083510 | |
| Pubmed | 3.24e-06 | 209 | 147 | 8 | 36779422 | ||
| Pubmed | Genome-wide atlas of gene expression in the adult mouse brain. | 3.37e-06 | 54 | 147 | 5 | 17151600 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.63e-06 | 363 | 147 | 10 | 14691545 | |
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 8306889 | ||
| Pubmed | Antagonism between retinoic acid and fibroblast growth factor signaling during limb development. | 4.08e-06 | 8 | 147 | 3 | 23623500 | |
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 18215124 | ||
| Pubmed | D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain. | 4.08e-06 | 8 | 147 | 3 | 34556581 | |
| Pubmed | Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation. | 4.26e-06 | 26 | 147 | 4 | 23974041 | |
| Pubmed | 4.42e-06 | 57 | 147 | 5 | 21122108 | ||
| Pubmed | 4.42e-06 | 57 | 147 | 5 | 21368052 | ||
| Pubmed | 4.98e-06 | 27 | 147 | 4 | 30063881 | ||
| Pubmed | BCL9L SUPT3H AFTPH NEBL KIF1A RALGAPB SPECC1L MED1 ZC3H11A PTPN13 DST CCT5 BAZ2A ATXN7 CSNK2A1 NFRKB TNRC6A LIMCH1 MED12 SON | 5.39e-06 | 1497 | 147 | 20 | 31527615 | |
| Pubmed | BCL9L CCP110 ARID1A BIRC6 ZC3H11A WDHD1 RTL9 TNRC6A AEBP2 HTATSF1 GCN1 | 5.45e-06 | 469 | 147 | 11 | 27634302 | |
| Pubmed | SMAP1 SAMD9 AFTPH MED1 ECPAS ARID1A SMTN DST MASTL CAMSAP1 MED12 | 5.79e-06 | 472 | 147 | 11 | 38943005 | |
| Pubmed | 5.80e-06 | 28 | 147 | 4 | 32868762 | ||
| Pubmed | Oxidative stress-dependent regulation of Forkhead box O4 activity by nemo-like kinase. | 6.10e-06 | 9 | 147 | 3 | 20874444 | |
| Pubmed | Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. | 6.10e-06 | 9 | 147 | 3 | 12183364 | |
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 9767163 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 30758286 | ||
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 33585465 | ||
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 8.82e-06 | 31 | 147 | 4 | 25838543 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXO1 FOXO3 CCP110 SMAP1 AFTPH GPN1 UBAP1 UPF1 CBL WDHD1 YAP1 CSNK2A1 LIMCH1 PAN3 MED12 SMAD4 | 8.92e-06 | 1038 | 147 | 16 | 26673895 |
| Pubmed | MON2 TPP2 MIA3 MYCBP2 VEZT RALGAPB PHF8 ARID1A BIRC6 PTPRT PTPN13 CCT5 CSNK2A1 TNRC6A PC GCN1 | 1.02e-05 | 1049 | 147 | 16 | 27880917 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AFTPH NEBL UPF1 MED1 ZC3H11A PTPN13 DST PAPOLA BAZ2A MASTL HTATSF1 CAMSAP1 PC GCN1 SON | 1.07e-05 | 934 | 147 | 15 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ARID4B PTBP2 KAT6A PHF8 MED1 JMJD1C BAZ2A CSNK2A1 NFRKB MASTL TAF1 PAX6 | 1.15e-05 | 608 | 147 | 12 | 36089195 |
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 15084259 | ||
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 17493607 | ||
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 20027618 | ||
| Pubmed | Hippi is essential for node cilia assembly and Sonic hedgehog signaling. | 1.19e-05 | 11 | 147 | 3 | 17027958 | |
| Pubmed | Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. | 1.29e-05 | 34 | 147 | 4 | 25915474 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 TPP2 UBR4 GPN1 UBAP1 ECPAS BIRC6 TSC22D1 WDHD1 PAPOLA CCT5 YAP1 CSNK2A1 NFRKB HTATSF1 LIMCH1 HECTD1 GCN1 RBX1 | 1.30e-05 | 1455 | 147 | 19 | 22863883 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.41e-05 | 184 | 147 | 7 | 32908313 | |
| Pubmed | 1.58e-05 | 12 | 147 | 3 | 20150232 | ||
| Pubmed | 1.58e-05 | 12 | 147 | 3 | 28213137 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24895270 | ||
| Pubmed | Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring. | 1.77e-05 | 2 | 147 | 2 | 25010393 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25966365 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 27470586 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21331365 | ||
| Pubmed | Foxo in T Cells Regulates Thermogenic Program through Ccr4/Ccl22 Axis. | 1.77e-05 | 2 | 147 | 2 | 31756626 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15069012 | ||
| Pubmed | Lower FOXO3 mRNA expression in granulosa cells is involved in unexplained infertility. | 1.77e-05 | 2 | 147 | 2 | 28621049 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20404140 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28430387 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20528922 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25952685 | ||
| Pubmed | ARID1A-mutated cervical cancer depends on the activation of YAP signaling. | 1.77e-05 | 2 | 147 | 2 | 34994156 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31477715 | ||
| Pubmed | MDM2 suppresses p73 function without promoting p73 degradation. | 1.77e-05 | 2 | 147 | 2 | 10207051 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20142102 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15550242 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 29716922 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21565617 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 9153193 | ||
| Interaction | HDAC1 interactions | SP1 NRIP1 SATB2 ARID4B MYCBP2 ZGRF1 UBR4 ECPAS MDM2 ARID1A BIRC6 JMJD1C PTPN13 DST PAPOLA CCT5 ZNF827 BAZ2A YAP1 CSNK2A1 PITX2 TNRC6A ZBTB5 TAF1 CAMSAP1 PC HECTD1 GCN1 MED12 TP73 SMAD4 RBX1 S100PBP | 7.19e-13 | 1108 | 140 | 33 | int:HDAC1 |
| Interaction | RCOR1 interactions | SP1 SATB2 MYCBP2 ZGRF1 UBR4 ECPAS BIRC6 JMJD1C PTPN13 DST WDHD1 ZNF827 CSNK2A1 ZBTB5 TAF1 CAMSAP1 PC GCN1 MED12 S100PBP | 2.29e-10 | 494 | 140 | 20 | int:RCOR1 |
| Interaction | PML interactions | FOXO1 SMAP1 SP1 GPN1 KAT6A MAMLD1 UPF1 MED1 MDM2 JMJD1C SMTN ZC3H11A NF1 ATXN7 YAP1 VWA5A CSNK2A1 NFRKB MASTL ZBTB5 POLK PC GCN1 TP73 RBX1 MAF | 1.21e-09 | 933 | 140 | 26 | int:PML |
| Interaction | PBX1 interactions | 7.65e-09 | 85 | 140 | 9 | int:PBX1 | |
| Interaction | KDM1A interactions | NRIP1 SATB2 MYCBP2 ZGRF1 UBR4 ISL1 PHF8 ECPAS BIRC6 JMJD1C SFMBT2 PTPN13 DST YAP1 CSNK2A1 TNRC6A TAF1 CAMSAP1 PC GCN1 MED12 TP73 SMAD4 S100PBP | 3.14e-08 | 941 | 140 | 24 | int:KDM1A |
| Interaction | AR interactions | FOXO1 BCL9L SP1 NRIP1 KIF1A MYCBP2 MED1 ECPAS MDM2 ARID1A FOXA1 JMJD1C MLH3 YAP1 CSNK2A1 NFRKB NPRL3 LIMCH1 TAF1 PAX6 GCN1 MED12 SMAD4 SON | 8.45e-08 | 992 | 140 | 24 | int:AR |
| Interaction | SIRT7 interactions | FOXO1 TPP2 KIF1A MYCBP2 UBR4 UPF1 ECPAS MDM2 ARID1A BIRC6 ZC3H11A DST NF1 CCT5 BAZ2A CSNK2A1 HECTD1 GCN1 MED12 SON | 2.20e-07 | 744 | 140 | 20 | int:SIRT7 |
| Interaction | HNF4A interactions | FOXO1 SP1 NRIP1 SATB2 ARID4B ISL1 MED1 MDM2 ARID1A ATXN7 NFRKB SMAD4 | 5.08e-07 | 275 | 140 | 12 | int:HNF4A |
| Interaction | PHF21A interactions | MYCBP2 ZGRF1 UBR4 ECPAS BIRC6 JMJD1C PTPN13 DST TNRC6A TAF1 PAX6 PC S100PBP | 8.25e-07 | 343 | 140 | 13 | int:PHF21A |
| Interaction | EP300 interactions | FOXO1 FOXO3 SP1 PTBP2 KAT6A UPF1 MED1 ECPAS MDM2 ARID1A CBL BIRC6 HOXB6 WDHD1 ATXN7 YAP1 CSNK2A1 PITX2 NPRL3 ZBTB5 PAX6 HECTD1 GCN1 TP73 SMAD4 SON MAF | 1.12e-06 | 1401 | 140 | 27 | int:EP300 |
| Interaction | ODF2 interactions | 1.63e-06 | 158 | 140 | 9 | int:ODF2 | |
| Interaction | PKNOX1 interactions | 1.65e-06 | 82 | 140 | 7 | int:PKNOX1 | |
| Interaction | BTRC interactions | FOXO3 SP1 HIVEP2 MYCBP2 RALGAPB UPF1 PHF8 MDM2 ARID1A FANCM FAM168A CCT5 YAP1 RTL9 TNRC6A AEBP2 PC SMAD4 RBX1 | 1.80e-06 | 775 | 140 | 19 | int:BTRC |
| Interaction | YAP1 interactions | FOXO1 BCL9L GPN1 UPF1 PHF8 MED1 MDM2 ARID1A FOXA1 JMJD1C ZC3H11A PTPN13 NF1 PAPOLA CCT5 BAZ2A YAP1 NFRKB TAF1 PC GCN1 MED12 TP73 | 1.89e-06 | 1095 | 140 | 23 | int:YAP1 |
| Interaction | YWHAQ interactions | FOXO1 FOXO3 CCP110 NRIP1 HIVEP2 AFTPH MYCBP2 SPECC1L UPF1 MED1 MDM2 CBL PTPN13 DST NF1 WDHD1 YAP1 CSNK2A1 PAN3 CAMSAP1 PC HECTD1 GCN1 | 2.69e-06 | 1118 | 140 | 23 | int:YWHAQ |
| Interaction | SMAD3 interactions | FOXO1 FOXO3 SP1 KAT6A ISL1 ARID1A CBL YAP1 PITX2 TAF1 PAX6 TP73 SMAD4 RBX1 | 2.91e-06 | 447 | 140 | 14 | int:SMAD3 |
| Interaction | VDR interactions | 2.97e-06 | 127 | 140 | 8 | int:VDR | |
| Interaction | NFYC interactions | 4.14e-06 | 177 | 140 | 9 | int:NFYC | |
| Interaction | CREBBP interactions | FOXO1 FOXO3 SP1 HIVEP2 KAT6A MDM2 ARID1A MEIS1 HOXB6 PAPOLA YAP1 CSNK2A1 PAX6 TP73 SMAD4 MAF | 4.30e-06 | 599 | 140 | 16 | int:CREBBP |
| Interaction | HEY1 interactions | 6.13e-06 | 140 | 140 | 8 | int:HEY1 | |
| Interaction | NLK interactions | 9.18e-06 | 70 | 140 | 6 | int:NLK | |
| Interaction | MED17 interactions | 1.21e-05 | 202 | 140 | 9 | int:MED17 | |
| Interaction | HIF1A interactions | MON2 FOXO3 SP1 ECPAS MDM2 CBL YAP1 CSNK2A1 HECTD1 GCN1 MED12 TP73 RBX1 | 1.28e-05 | 441 | 140 | 13 | int:HIF1A |
| Interaction | MED1 interactions | 1.41e-05 | 206 | 140 | 9 | int:MED1 | |
| Interaction | LDB1 interactions | 1.58e-05 | 115 | 140 | 7 | int:LDB1 | |
| Interaction | BRCA1 interactions | FOXO3 TPP2 SP1 NRIP1 UBR4 GPN1 UPF1 ECPAS ARID1A FANCM SMTN ZC3H11A DST NF1 WDHD1 CCT5 ZNF827 CSNK2A1 TNRC6A GCN1 MED12 TP73 SMAD4 | 1.64e-05 | 1249 | 140 | 23 | int:BRCA1 |
| Interaction | ZYX interactions | FOXO1 CCP110 NEBL UBAP1 FOXA1 CBL PAPOLA YAP1 TNRC6A LIMCH1 CAMSAP1 | 1.94e-05 | 329 | 140 | 11 | int:ZYX |
| Interaction | TRIM47 interactions | 2.03e-05 | 48 | 140 | 5 | int:TRIM47 | |
| Interaction | TP73 interactions | 2.42e-05 | 169 | 140 | 8 | int:TP73 | |
| Interaction | GPN1 interactions | 2.44e-05 | 123 | 140 | 7 | int:GPN1 | |
| Interaction | SIRT1 interactions | FOXO1 FOXO3 CACNA1C ARID4B KAT6A MDM2 PAPOLA YAP1 CSNK2A1 PITX2 TP73 RBX1 | 3.14e-05 | 412 | 140 | 12 | int:SIRT1 |
| Interaction | AHR interactions | 3.84e-05 | 132 | 140 | 7 | int:AHR | |
| Interaction | SKP2 interactions | 4.29e-05 | 296 | 140 | 10 | int:SKP2 | |
| Interaction | NAA40 interactions | TPP2 AFTPH NEBL UPF1 MED1 FOXA1 FOXB1 ZC3H11A PTPN13 DST PAPOLA BAZ2A MASTL HTATSF1 LIMCH1 CAMSAP1 PC GCN1 SON | 4.77e-05 | 978 | 140 | 19 | int:NAA40 |
| Interaction | HERC2 interactions | CCP110 MYCBP2 UBR4 DDR2 SPECC1L UPF1 MED1 MDM2 BIRC6 DST ZBTB5 TAF1 HECTD1 | 5.02e-05 | 503 | 140 | 13 | int:HERC2 |
| Interaction | PAX6 interactions | SATB2 ARID4B ARID1A MEIS2 CSNK2A1 NFRKB TAF1 PAX6 TP73 SMAD4 MAF | 5.12e-05 | 366 | 140 | 11 | int:PAX6 |
| Interaction | POU5F1 interactions | TPP2 SP1 PTBP2 UBR4 MUC16 UPF1 ECPAS ARID1A JMJD1C CCT5 CSNK2A1 NFRKB TAF1 GCN1 | 5.75e-05 | 584 | 140 | 14 | int:POU5F1 |
| Interaction | TLE3 interactions | BCL9L HIVEP2 ARID1A FOXA1 CBL FOXB1 NFRKB TNRC6A MASTL PAX6 SON | 6.52e-05 | 376 | 140 | 11 | int:TLE3 |
| Interaction | SIN3A interactions | SP1 ARID4B UBR4 ARID1A YAP1 CSNK2A1 ZBTB5 TAF1 HECTD1 SMAD4 MAF | 7.17e-05 | 380 | 140 | 11 | int:SIN3A |
| Interaction | CTNNB1 interactions | FOXO1 FOXO3 BCL9L SP1 VEZT DDR2 SPECC1L CBL FOXB1 TSC22D1 ZC3H11A PTPN13 DST YAP1 CSNK2A1 PITX2 LIMCH1 HECTD1 SMAD4 | 7.22e-05 | 1009 | 140 | 19 | int:CTNNB1 |
| Interaction | DNMT1 interactions | 7.27e-05 | 254 | 140 | 9 | int:DNMT1 | |
| Interaction | CRX interactions | 7.27e-05 | 254 | 140 | 9 | int:CRX | |
| Interaction | KAT2B interactions | 7.72e-05 | 256 | 140 | 9 | int:KAT2B | |
| Interaction | EGLN3 interactions | FOXO3 CCP110 MYCBP2 UBR4 GPN1 PHF8 ECPAS MDM2 CBL BIRC6 JMJD1C PTPN13 FAM168A WDHD1 CCT5 YAP1 CSNK2A1 MASTL ZBTB5 CAMSAP1 HECTD1 GCN1 | 8.65e-05 | 1296 | 140 | 22 | int:EGLN3 |
| Interaction | SREBF1 interactions | 8.65e-05 | 150 | 140 | 7 | int:SREBF1 | |
| Interaction | SMARCA4 interactions | FOXO1 SP1 ARID4B KAT6A UPF1 MDM2 ARID1A NF1 YAP1 CSNK2A1 PAX6 HECTD1 | 9.41e-05 | 462 | 140 | 12 | int:SMARCA4 |
| Interaction | POLR2A interactions | NRIP1 GPN1 UPF1 PHF8 MED1 NF1 FAM168A WDHD1 YAP1 CSNK2A1 HTATSF1 MED12 RBX1 | 9.52e-05 | 536 | 140 | 13 | int:POLR2A |
| Interaction | USP7 interactions | FOXO3 CACNA1C MRC1 CCP110 SP1 VEZT ZGRF1 DOCK10 PHF8 MDM2 MEIS2 TSC22D1 ZC3H11A DST YAP1 CSNK2A1 TAF1 CAMSAP1 PC DNAH5 SMAD4 MAF | 1.04e-04 | 1313 | 140 | 22 | int:USP7 |
| Interaction | HDAC2 interactions | TPP2 SP1 NRIP1 SATB2 ARID4B MYCBP2 MDM2 ARID1A JMJD1C CCT5 ZNF827 YAP1 CSNK2A1 TP73 SMAD4 RBX1 MAF | 1.07e-04 | 865 | 140 | 17 | int:HDAC2 |
| Interaction | JUN interactions | SP1 NRIP1 SATB2 MIA3 PTBP2 MDM2 YAP1 CSNK2A1 TAF1 TP73 SMAD4 MAF | 1.11e-04 | 470 | 140 | 12 | int:JUN |
| Interaction | UBE2L3 interactions | 1.16e-04 | 211 | 140 | 8 | int:UBE2L3 | |
| Interaction | IER2 interactions | 1.23e-04 | 37 | 140 | 4 | int:IER2 | |
| Interaction | OAZ1 interactions | 1.37e-04 | 38 | 140 | 4 | int:OAZ1 | |
| Interaction | SNRNP40 interactions | ESPN BCL9L PTBP2 KAT6A PHF8 ARID1A CCT5 BAZ2A NFRKB MASTL HTATSF1 HECTD1 MED12 SON | 1.44e-04 | 637 | 140 | 14 | int:SNRNP40 |
| Interaction | CHIA interactions | 1.52e-04 | 39 | 140 | 4 | int:CHIA | |
| Interaction | SUZ12 interactions | BCL9L CCP110 UPF1 MDM2 BIRC6 NF1 WDHD1 RTL9 TNRC6A AEBP2 HTATSF1 HECTD1 GCN1 SON | 1.61e-04 | 644 | 140 | 14 | int:SUZ12 |
| Interaction | DDX5 interactions | FOXO1 SP1 KAT6A UPF1 MDM2 CBL CCT5 YAP1 MBD5 HECTD1 MED12 SMAD4 RBX1 | 1.69e-04 | 568 | 140 | 13 | int:DDX5 |
| Interaction | SMARCC2 interactions | SP1 SAMD9 ARID4B MYCBP2 ARID1A FOXA1 YAP1 CSNK2A1 PAX6 SMAD4 | 1.83e-04 | 353 | 140 | 10 | int:SMARCC2 |
| Interaction | MT2A interactions | 1.85e-04 | 41 | 140 | 4 | int:MT2A | |
| Interaction | ITGB3 interactions | 1.88e-04 | 170 | 140 | 7 | int:ITGB3 | |
| Interaction | NFIX interactions | 1.91e-04 | 227 | 140 | 8 | int:NFIX | |
| Interaction | ETS1 interactions | 2.02e-04 | 121 | 140 | 6 | int:ETS1 | |
| Interaction | RBL1 interactions | 2.02e-04 | 121 | 140 | 6 | int:RBL1 | |
| Interaction | MS4A4A interactions | 2.03e-04 | 42 | 140 | 4 | int:MS4A4A | |
| Interaction | CPNE5 interactions | 2.03e-04 | 42 | 140 | 4 | int:CPNE5 | |
| Interaction | TLX1 interactions | 2.25e-04 | 175 | 140 | 7 | int:TLX1 | |
| Interaction | YWHAH interactions | FOXO1 FOXO3 CCP110 NRIP1 HIVEP2 AFTPH MYCBP2 RALGAPB SPECC1L MED1 CBL PTPN13 DST NF1 YAP1 LIMCH1 PAN3 CAMSAP1 HECTD1 | 2.26e-04 | 1102 | 140 | 19 | int:YWHAH |
| Interaction | MED12 interactions | 2.33e-04 | 176 | 140 | 7 | int:MED12 | |
| Interaction | PLK1 interactions | FOXO3 SATB2 KIF1A MYCBP2 UPF1 MED1 MDM2 CBL BIRC6 MASTL HECTD1 TP73 | 2.36e-04 | 510 | 140 | 12 | int:PLK1 |
| Interaction | DUSP2 interactions | 2.53e-04 | 81 | 140 | 5 | int:DUSP2 | |
| Interaction | SAP130 interactions | 2.76e-04 | 181 | 140 | 7 | int:SAP130 | |
| Interaction | MEN1 interactions | UBR4 UPF1 PHF8 MED1 ECPAS ARID1A JMJD1C FOXB1 ZC3H11A WDHD1 PAPOLA BAZ2A YAP1 CSNK2A1 TAF1 MED12 SMAD4 SON | 2.81e-04 | 1029 | 140 | 18 | int:MEN1 |
| Interaction | IRF1 interactions | 2.83e-04 | 83 | 140 | 5 | int:IRF1 | |
| Interaction | ESF1 interactions | 2.86e-04 | 182 | 140 | 7 | int:ESF1 | |
| Interaction | DYNLT1 interactions | 2.87e-04 | 241 | 140 | 8 | int:DYNLT1 | |
| Interaction | GOLGA1 interactions | 2.95e-04 | 183 | 140 | 7 | int:GOLGA1 | |
| Interaction | CDKN1A interactions | 2.97e-04 | 375 | 140 | 10 | int:CDKN1A | |
| Interaction | SMAD1 interactions | 3.03e-04 | 243 | 140 | 8 | int:SMAD1 | |
| Interaction | RSPH1 interactions | 3.10e-04 | 131 | 140 | 6 | int:RSPH1 | |
| Interaction | CLTB interactions | 3.16e-04 | 185 | 140 | 7 | int:CLTB | |
| Interaction | CLIP4 interactions | 3.16e-04 | 47 | 140 | 4 | int:CLIP4 | |
| Interaction | SFN interactions | FOXO1 FOXO3 CCP110 AFTPH MYCBP2 MDM2 CBL PTPN13 DST YAP1 CSNK2A1 PAN3 CAMSAP1 HECTD1 | 3.35e-04 | 692 | 140 | 14 | int:SFN |
| Interaction | MYB interactions | 3.36e-04 | 133 | 140 | 6 | int:MYB | |
| Interaction | AMOT interactions | 3.39e-04 | 312 | 140 | 9 | int:AMOT | |
| Interaction | JADE2 interactions | 3.42e-04 | 48 | 140 | 4 | int:JADE2 | |
| Interaction | NFIA interactions | 3.48e-04 | 188 | 140 | 7 | int:NFIA | |
| Interaction | BRCA2 interactions | 3.58e-04 | 384 | 140 | 10 | int:BRCA2 | |
| Interaction | DDB1 interactions | CCP110 SUPT3H ARID4B GPN1 PHF8 MED1 MDM2 CBL CSNK2A1 TAF1 HECTD1 MED12 TP73 RBX1 | 3.61e-04 | 697 | 140 | 14 | int:DDB1 |
| Interaction | FBXO45 interactions | 3.72e-04 | 88 | 140 | 5 | int:FBXO45 | |
| Interaction | AKT1 interactions | FOXO1 FOXO3 SP1 KAT6A MDM2 SFMBT2 MLH3 NF1 FAM168A CCT5 YAP1 CSNK2A1 SMAD4 | 3.75e-04 | 617 | 140 | 13 | int:AKT1 |
| Interaction | UPF3B interactions | 3.79e-04 | 136 | 140 | 6 | int:UPF3B | |
| Interaction | HOXB4 interactions | 3.98e-04 | 21 | 140 | 3 | int:HOXB4 | |
| Interaction | BAG2 interactions | FOXO1 SMAP1 SP1 FOXA1 CBL ARMC1 WDHD1 PAPOLA YAP1 NFRKB MED12 MBNL3 RBX1 | 4.05e-04 | 622 | 140 | 13 | int:BAG2 |
| Interaction | RBPJ interactions | 4.07e-04 | 254 | 140 | 8 | int:RBPJ | |
| Interaction | TRIM9 interactions | 4.12e-04 | 90 | 140 | 5 | int:TRIM9 | |
| Interaction | NUP43 interactions | BCL9L ARID4B PHF8 ARID1A JMJD1C SMTN DST CCT5 BAZ2A TOX3 NFRKB MED12 SON | 4.24e-04 | 625 | 140 | 13 | int:NUP43 |
| Interaction | CALM1 interactions | TPP2 CACNA1C CCP110 SP1 AMPH KIF1A MYCBP2 UBR4 CBL ARMC1 DST YAP1 CSNK2A1 | 4.30e-04 | 626 | 140 | 13 | int:CALM1 |
| Interaction | RB1 interactions | 4.38e-04 | 394 | 140 | 10 | int:RB1 | |
| Interaction | SIRT6 interactions | FOXO3 MIA3 MYCBP2 UPF1 MED1 MDM2 ARID1A NF1 WDHD1 CCT5 CAMSAP1 HECTD1 MED12 | 4.43e-04 | 628 | 140 | 13 | int:SIRT6 |
| Interaction | MOCS2 interactions | 4.59e-04 | 22 | 140 | 3 | int:MOCS2 | |
| GeneFamily | CD molecules|Mucins | 4.71e-06 | 21 | 99 | 4 | 648 | |
| GeneFamily | Forkhead boxes | 8.86e-05 | 43 | 99 | 4 | 508 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.36e-04 | 25 | 99 | 3 | 775 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.04e-03 | 9 | 99 | 2 | 527 | |
| GeneFamily | UPF1 like RNA helicases | 1.58e-03 | 11 | 99 | 2 | 1169 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.58e-03 | 11 | 99 | 2 | 1168 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.58e-03 | 11 | 99 | 2 | 1025 | |
| GeneFamily | AT-rich interaction domain containing | 2.98e-03 | 15 | 99 | 2 | 418 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 3.83e-03 | 17 | 99 | 2 | 1059 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.83e-03 | 17 | 99 | 2 | 486 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 NRIP1 AMPH SATB2 HIVEP2 MYCBP2 DDR2 KAT6A MAMLD1 SPECC1L PHF8 MED1 MEIS2 RGL1 PTPN13 DST FAM168A WDHD1 YAP1 CSNK2A1 SMAD4 SON | 2.36e-09 | 856 | 146 | 22 | M4500 |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | MON2 AFTPH MYCBP2 TSC22D1 ZC3H11A BAZ2A VWA5A NFRKB TAF1 SON S100PBP | 1.56e-08 | 198 | 146 | 11 | M7605 |
| Coexpression | ZHOU_PANCREATIC_BETA_CELL | 2.96e-07 | 11 | 146 | 4 | MM1247 | |
| Coexpression | ZHOU_PANCREATIC_BETA_CELL | 2.96e-07 | 11 | 146 | 4 | M1863 | |
| Coexpression | BENPORATH_NOS_TARGETS | 7.65e-07 | 179 | 146 | 9 | M14573 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 3.04e-06 | 158 | 146 | 8 | M372 | |
| Coexpression | BENPORATH_OCT4_TARGETS | DUSP12 FOXO1 COL12A1 NEBL KAT6A PHF8 MEIS2 TSC22D1 TNRC6A MED12 | 5.55e-06 | 290 | 146 | 10 | M17183 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 7.66e-06 | 84 | 146 | 6 | M13008 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 FOXO1 HIVEP2 SAMD9 ARID4B MYCBP2 UBR4 KAT6A RALGAPB DOCK10 MED1 ARID1A CBL BIRC6 JMJD1C SFMBT2 HIVEP3 ZC3H11A PAPOLA ATXN7 VWA5A SON MAF | 8.68e-06 | 1492 | 146 | 23 | M40023 |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 9.00e-06 | 24 | 146 | 4 | M1437 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 9.00e-06 | 24 | 146 | 4 | MM627 | |
| Coexpression | BENPORATH_NANOG_TARGETS | DUSP12 FOXO1 FOXO3 BCL9L COL12A1 NEBL GPN1 KAT6A PHF8 ECPAS TSC22D1 WDHD1 YAP1 VWA5A PITX2 TNRC6A MED12 SON | 1.02e-05 | 988 | 146 | 18 | M6616 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FOXO3 NRIP1 SATB2 HIVEP2 MYCBP2 KAT6A MAMLD1 SPECC1L MEIS2 DST YAP1 LIMCH1 | 1.24e-05 | 466 | 146 | 12 | M13522 |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 1.71e-05 | 200 | 146 | 8 | M4884 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | FOXO1 MIA3 HIVEP2 NEBL KIF1A MYCBP2 DOCK10 SPECC1L ECPAS MDM2 MEIS2 RGL1 USF3 DST DNAH5 HECTD1 IL17RB | 2.19e-05 | 946 | 146 | 17 | M39169 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | 2.20e-05 | 340 | 146 | 10 | M2012 | |
| Coexpression | MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL | 2.48e-05 | 153 | 146 | 7 | M39171 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | SMAP1 ARID4B RALGAPB ECPAS NF1 FAM168A HTATSF1 LIMCH1 CAMSAP1 SMAD4 SON | 3.01e-05 | 429 | 146 | 11 | M29 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 4.17e-05 | 166 | 146 | 7 | M6826 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 4.83e-05 | 116 | 146 | 6 | M2379 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MON2 DUSP12 FOXO1 TPP2 SATB2 DOCK10 ARID1A SFMBT2 MEIS1 MEIS2 ARMC1 CCT5 PITX2 TOX3 AEBP2 LIMCH1 MAF | 4.90e-05 | 1009 | 146 | 17 | M157 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.91e-05 | 300 | 146 | 9 | M8702 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 5.07e-05 | 117 | 146 | 6 | MM931 | |
| Coexpression | BENPORATH_SOX2_TARGETS | DUSP12 FOXO1 COL12A1 ARID4B NEBL KAT6A PHF8 ECPAS TSC22D1 FAM168A VWA5A PITX2 TNRC6A MED12 | 6.45e-05 | 734 | 146 | 14 | M3835 |
| Coexpression | TOMLINS_PROSTATE_CANCER_DN | 7.22e-05 | 40 | 146 | 4 | M11504 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | FOXO3 BCL9L CCP110 COL12A1 SAMD9 GPN1 ARID1A CBL JMJD1C TSC22D1 DST YAP1 MASTL PC S100PBP | 7.65e-05 | 843 | 146 | 15 | M2356 |
| Coexpression | PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN | 8.77e-05 | 42 | 146 | 4 | M41055 | |
| Coexpression | LEF1_UP.V1_DN | 8.85e-05 | 187 | 146 | 7 | M2903 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 1.04e-04 | 192 | 146 | 7 | M8272 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.15e-04 | 85 | 146 | 5 | M10575 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.21e-04 | 86 | 146 | 5 | M39247 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.22e-04 | 137 | 146 | 6 | M39241 | |
| Coexpression | GSE27786_CD8_TCELL_VS_MONO_MAC_UP | 1.30e-04 | 199 | 146 | 7 | M4848 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN | 1.30e-04 | 199 | 146 | 7 | M7511 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 1.30e-04 | 199 | 146 | 7 | M6839 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 1.30e-04 | 199 | 146 | 7 | M4444 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 1.30e-04 | 199 | 146 | 7 | M6987 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TPP2 NRIP1 AMPH HIVEP2 DOCK10 MDM2 JMJD1C MS4A4A USF3 ATXN7 HECTD1 | 1.33e-04 | 507 | 146 | 11 | MM1030 |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 1.34e-04 | 200 | 146 | 7 | M3399 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.34e-04 | 200 | 146 | 7 | M9889 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP | 1.34e-04 | 200 | 146 | 7 | M5613 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 1.34e-04 | 268 | 146 | 8 | M45696 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MON2 FOXO1 SP1 HIVEP2 PLEKHH1 TSC22D1 NF1 PAPOLA VWA5A CSNK2A1 LIMCH1 HECTD1 SMAD4 MAF | 1.74e-04 | 807 | 146 | 14 | M16651 |
| Coexpression | ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR | 2.14e-04 | 97 | 146 | 5 | M39215 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 2.24e-04 | 98 | 146 | 5 | M40018 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 2.25e-04 | 289 | 146 | 8 | M2196 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL | 2.38e-04 | 155 | 146 | 6 | M45695 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_664_5P_GENES | 2.90e-04 | 57 | 146 | 4 | MM17505 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 2.92e-04 | 161 | 146 | 6 | M7728 | |
| Coexpression | HAN_SATB1_TARGETS_DN | 3.39e-04 | 388 | 146 | 9 | M15491 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 3.44e-04 | 166 | 146 | 6 | M8129 | |
| Coexpression | WONG_ENDMETRIUM_CANCER_UP | 3.56e-04 | 25 | 146 | 3 | M16201 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 3.67e-04 | 168 | 146 | 6 | M45039 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | MRC1 SP1 NRIP1 CUX2 CBL BIRC6 JMJD1C MEIS1 MEIS2 EDNRA HIVEP3 RGL1 ZC3H11A PAPOLA CSNK2A1 PCDH19 TNRC6A TMEM255A MBNL3 MAF | 2.78e-07 | 801 | 139 | 20 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SP1 NRIP1 CBL BIRC6 MEIS1 MEIS2 EDNRA RGL1 ZC3H11A CSNK2A1 PCDH19 TMEM255A MBNL3 MAF | 5.74e-07 | 413 | 139 | 14 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SP1 NRIP1 ISL1 ARID1A CBL BIRC6 JMJD1C MEIS1 MEIS2 EDNRA RGL1 HOXB6 ZC3H11A CSNK2A1 PITX2 TOX3 TMEM255A MBNL3 MAF | 1.58e-06 | 815 | 139 | 19 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.03e-05 | 210 | 139 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.45e-05 | 167 | 139 | 8 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SP1 NRIP1 ARID1A CBL BIRC6 MEIS1 MEIS2 EDNRA RGL1 ZC3H11A PAPOLA CSNK2A1 PITX2 TNRC6A TMEM255A MBNL3 MAF | 2.14e-05 | 806 | 139 | 17 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | NEBL DDR2 ISL1 FOXA1 ARMC1 EDNRA DST PITX2 TOX3 LIMCH1 TMEM255A SON | 2.56e-05 | 428 | 139 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CCP110 ARID4B KIF1A ZGRF1 KAT6A MAMLD1 MDM2 ARID1A PLEKHH1 TNRC6A AEBP2 TAF1 HECTD1 SON | 3.72e-05 | 595 | 139 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.37e-05 | 259 | 139 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.37e-05 | 259 | 139 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 5.98e-05 | 150 | 139 | 7 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SP1 NRIP1 CBL BIRC6 JMJD1C MEIS1 MEIS2 EDNRA ZC3H11A VWA5A CSNK2A1 TNRC6A HTATSF1 TMEM255A MBNL3 MAF | 6.15e-05 | 790 | 139 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SP1 NRIP1 COL12A1 CBL BIRC6 JMJD1C MEIS1 MEIS2 EDNRA ZC3H11A CSNK2A1 TNRC6A HTATSF1 TMEM255A MBNL3 MAF | 7.03e-05 | 799 | 139 | 16 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SP1 NRIP1 BIRC6 MEIS1 MEIS2 EDNRA RGL1 ZC3H11A CSNK2A1 TMEM255A MBNL3 | 7.15e-05 | 403 | 139 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.98e-05 | 277 | 139 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 9.33e-05 | 161 | 139 | 7 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.49e-05 | 279 | 139 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 9.70e-05 | 162 | 139 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | NRIP1 COL12A1 JMJD1C MEIS1 MEIS2 ZC3H11A CSNK2A1 TMEM255A MAF | 1.00e-04 | 281 | 139 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CCP110 CUX2 COL12A1 PTBP2 DDR2 DOCK10 MUC16 MEIS1 MEIS2 EDNRA TSC22D1 PTPN13 WDHD1 MASTL TMEM255A MBNL3 | 1.11e-04 | 831 | 139 | 16 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | NEBL DDR2 ISL1 FOXA1 EDNRA DST PITX2 TOX3 LIMCH1 TMEM255A SON | 1.24e-04 | 429 | 139 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 1.28e-04 | 118 | 139 | 6 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | ARID4B NEBL VEZT DDR2 ISL1 FOXA1 ARMC1 EDNRA DST PAPOLA PITX2 TOX3 LIMCH1 TMEM255A RBX1 SON | 1.44e-04 | 850 | 139 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.57e-04 | 175 | 139 | 7 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 1.62e-04 | 42 | 139 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | TBX22 CACNA1C CUX2 AFTPH MAMLD1 DOCK10 ISL1 MEIS1 MEIS2 PLEKHH1 HIVEP3 PTPN13 VWA5A PCDH19 TOX3 PAX6 MBNL3 | 2.14e-04 | 973 | 139 | 17 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | FOXO1 VWC2 HIVEP2 ZGRF1 DDR2 MED1 FOXA1 MEIS1 MEIS2 EDNRA ZNF827 VWA5A PCDH19 CAMSAP1 TMEM255A | 2.16e-04 | 791 | 139 | 15 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.29e-04 | 385 | 139 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 2.44e-04 | 388 | 139 | 10 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | TBX22 CACNA1C CCP110 NRIP1 CUX2 KIF1A MAMLD1 DOCK10 ISL1 MEIS2 PLEKHH1 HIVEP3 VWA5A PCDH19 TOX3 PAX6 SRRM3 | 2.44e-04 | 984 | 139 | 17 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ARID4B PTBP2 ZGRF1 KAT6A MAMLD1 ECPAS MDM2 ARID1A ZC3H11A TAF1 PAX6 HECTD1 SON | 2.56e-04 | 629 | 139 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | CCP110 KIF1A PTBP2 FOXA1 BIRC6 PLEKHH1 RGL1 FOXB1 PTPN13 DST PAPOLA TOX3 MASTL PAX6 PAN3 GCN1 MAF | 2.75e-04 | 994 | 139 | 17 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.81e-04 | 395 | 139 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.83e-04 | 323 | 139 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | NRIP1 CUX2 MYCBP2 VEZT ISL1 MED1 ECPAS FOXA1 BIRC6 EDNRA RGL1 PITX2 CAMSAP1 GCN1 SON | 3.10e-04 | 818 | 139 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 3.31e-04 | 91 | 139 | 5 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SP1 NRIP1 MEIS1 MEIS2 EDNRA ZC3H11A CSNK2A1 TMEM255A MBNL3 MAF | 3.49e-04 | 406 | 139 | 10 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | SP1 NRIP1 BIRC6 MEIS1 MEIS2 EDNRA ZC3H11A TMEM255A MBNL3 MAF | 3.70e-04 | 409 | 139 | 10 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | ARID4B NEBL VEZT PTBP2 DDR2 ISL1 FOXA1 EDNRA DST PITX2 TOX3 LIMCH1 TMEM255A RBX1 SON | 3.89e-04 | 836 | 139 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 5.01e-04 | 152 | 139 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 5.01e-04 | 152 | 139 | 6 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | SATB2 CUX2 NEBL VEZT DDR2 ISL1 FOXA1 CBL MEIS2 EDNRA DST PITX2 LIMCH1 TMEM255A | 5.31e-04 | 769 | 139 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.77e-04 | 284 | 139 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 5.94e-04 | 157 | 139 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.39e-04 | 105 | 139 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.14e-04 | 225 | 139 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SP1 NRIP1 COL12A1 CBL BIRC6 MEIS1 MEIS2 EDNRA ZC3H11A VWA5A CSNK2A1 TNRC6A MBNL3 MAF | 7.53e-04 | 797 | 139 | 14 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 7.95e-04 | 166 | 139 | 6 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SP1 NRIP1 ARID1A BIRC6 JMJD1C MEIS1 MEIS2 EDNRA RGL1 ZC3H11A CSNK2A1 TMEM255A MBNL3 MAF | 8.20e-04 | 804 | 139 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 8.24e-04 | 64 | 139 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 8.74e-04 | 65 | 139 | 4 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-09 | 200 | 147 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-08 | 193 | 147 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-08 | 199 | 147 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-07 | 180 | 147 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-07 | 188 | 147 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-07 | 188 | 147 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-07 | 188 | 147 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.55e-07 | 192 | 147 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-07 | 192 | 147 | 8 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.66e-07 | 193 | 147 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.66e-07 | 193 | 147 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-07 | 194 | 147 | 8 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-07 | 194 | 147 | 8 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-07 | 194 | 147 | 8 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-07 | 194 | 147 | 8 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.35e-07 | 199 | 147 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-07 | 200 | 147 | 8 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-06 | 173 | 147 | 7 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 175 | 147 | 7 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 176 | 147 | 7 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-06 | 180 | 147 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-06 | 181 | 147 | 7 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-06 | 181 | 147 | 7 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-06 | 181 | 147 | 7 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.50e-06 | 182 | 147 | 7 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-06 | 185 | 147 | 7 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-06 | 186 | 147 | 7 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.99e-06 | 187 | 147 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-06 | 187 | 147 | 7 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-06 | 187 | 147 | 7 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.99e-06 | 187 | 147 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.09e-06 | 188 | 147 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 188 | 147 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.20e-06 | 189 | 147 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-06 | 189 | 147 | 7 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.32e-06 | 190 | 147 | 7 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 3.43e-06 | 191 | 147 | 7 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.43e-06 | 191 | 147 | 7 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.43e-06 | 191 | 147 | 7 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.43e-06 | 191 | 147 | 7 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-06 | 191 | 147 | 7 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 192 | 147 | 7 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-06 | 192 | 147 | 7 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-06 | 192 | 147 | 7 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 192 | 147 | 7 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.55e-06 | 192 | 147 | 7 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.68e-06 | 193 | 147 | 7 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.68e-06 | 193 | 147 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 193 | 147 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-06 | 193 | 147 | 7 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.68e-06 | 193 | 147 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 193 | 147 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.68e-06 | 193 | 147 | 7 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 194 | 147 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.80e-06 | 194 | 147 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 194 | 147 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-06 | 195 | 147 | 7 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-06 | 195 | 147 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-06 | 195 | 147 | 7 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-06 | 195 | 147 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 195 | 147 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-06 | 195 | 147 | 7 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-06 | 195 | 147 | 7 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 195 | 147 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-06 | 196 | 147 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.21e-06 | 197 | 147 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-COVID-19_Mild-Others-RBC|COVID-19_Mild / Disease, condition lineage and cell class | 4.21e-06 | 197 | 147 | 7 | 3bae601e5d9689ea57e923814af8cdcae690becc | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 198 | 147 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.50e-06 | 199 | 147 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.50e-06 | 199 | 147 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.65e-06 | 200 | 147 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.65e-06 | 200 | 147 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.88e-06 | 148 | 147 | 6 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.03e-05 | 149 | 147 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-05 | 161 | 147 | 6 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 1.90e-05 | 166 | 147 | 6 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.90e-05 | 166 | 147 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-05 | 167 | 147 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 170 | 147 | 6 | c638dfde9ce30190abbe0caea1c3eb874af09857 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-05 | 170 | 147 | 6 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 170 | 147 | 6 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 172 | 147 | 6 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 173 | 147 | 6 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 173 | 147 | 6 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-05 | 174 | 147 | 6 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-05 | 176 | 147 | 6 | fb718a6b07aa5d56600263280afa530bcb63db42 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-05 | 177 | 147 | 6 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.72e-05 | 177 | 147 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 178 | 147 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.71e-07 | 191 | 143 | 10 | 4279_DN | |
| Drug | geldanamycin | TPP2 COL12A1 DDR2 KAT6A MDM2 FANCM CBL JMJD1C ZC3H11A DST NF1 CSNK2A1 HECTD1 | 6.58e-07 | 371 | 143 | 13 | ctd:C001277 |
| Drug | 5149715; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.83e-06 | 199 | 143 | 9 | 890_UP | |
| Drug | AC1ND2OB | 7.08e-06 | 265 | 143 | 10 | CID004568637 | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.09e-05 | 193 | 143 | 8 | 4690_DN | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A | 3.09e-05 | 193 | 143 | 8 | 1749_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.09e-05 | 193 | 143 | 8 | 4973_DN | |
| Drug | Asbestos, Crocidolite | FOXO1 FOXO3 SP1 NRIP1 CUX2 COL12A1 HIVEP2 ARID1A JMJD1C MEIS1 HIVEP3 TSC22D1 DST NF1 YAP1 VWA5A OR1E2 LIMCH1 PC SRRM3 MED12 | 3.24e-05 | 1241 | 143 | 21 | ctd:D017638 |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 3.32e-05 | 195 | 143 | 8 | 1163_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 3.32e-05 | 195 | 143 | 8 | 2264_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 4984_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 6010_DN | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 1311_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 7482_DN | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 4603_UP | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 7428_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 4765_DN | |
| Disease | Colorectal Carcinoma | TBX22 SATB2 ITPRID1 ARID1A DSCAML1 PTPRT SMTN HIVEP3 CDH22 MLH3 NF1 YAP1 OR1E2 SMAD4 MAF | 2.09e-06 | 702 | 145 | 15 | C0009402 |
| Disease | Adenoid Cystic Carcinoma | 1.03e-05 | 100 | 145 | 6 | C0010606 | |
| Disease | macrophage mannose receptor 1 measurement | 2.40e-05 | 2 | 145 | 2 | EFO_0020548 | |
| Disease | extrapulmonary tuberculosis | 2.48e-05 | 12 | 145 | 3 | MONDO_0000368 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.21e-05 | 13 | 145 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Adenocarcinoma Of Esophagus | 4.07e-05 | 14 | 145 | 3 | C0279628 | |
| Disease | Breast Carcinoma | NRIP1 MDM2 ARID1A FOXA1 MEIS1 ZC3H11A CCT5 YAP1 TOX3 MED12 TP73 | 7.51e-05 | 538 | 145 | 11 | C0678222 |
| Disease | Malignant neoplasm of breast | NRIP1 UBR4 MDM2 ARID1A FOXA1 MEIS1 EDNRA RGL1 SLC39A12 ZC3H11A NF1 CCT5 YAP1 TOX3 MED12 TP73 | 8.09e-05 | 1074 | 145 | 16 | C0006142 |
| Disease | monocyte count | FOXO1 NRIP1 SUPT3H ARID4B DDR2 DOCK10 CBL MEIS1 HIVEP3 MS4A4A SLC39A12 NF1 HFM1 PAN3 MBD5 MUC22 MYO16 TMEM255A | 8.80e-05 | 1320 | 145 | 18 | EFO_0005091 |
| Disease | cognitive inhibition measurement | 1.08e-04 | 50 | 145 | 4 | EFO_0007969 | |
| Disease | JUVENILE MYELOMONOCYTIC LEUKEMIA | 1.43e-04 | 4 | 145 | 2 | 607785 | |
| Disease | Axenfeld-Rieger Syndrome, Type 1 | 1.43e-04 | 4 | 145 | 2 | C3714873 | |
| Disease | ANTERIOR SEGMENT DYSGENESIS 5 | 1.43e-04 | 4 | 145 | 2 | C4310809 | |
| Disease | Juvenile myelomonocytic leukemia | 1.43e-04 | 4 | 145 | 2 | cv:C0349639 | |
| Disease | Noonan Syndrome | 2.18e-04 | 24 | 145 | 3 | C0028326 | |
| Disease | Alveolar rhabdomyosarcoma | 2.38e-04 | 5 | 145 | 2 | C0206655 | |
| Disease | neuroimaging measurement | FOXO3 MRC1 SP1 ANO2 SUPT3H SAMD9 JMJD1C MEIS2 SLC39A12 NF1 TOX3 TNRC6A PC MYO16 MAF | 2.60e-04 | 1069 | 145 | 15 | EFO_0004346 |
| Disease | monocyte percentage of leukocytes | FOXO1 NRIP1 SUPT3H ARID4B DOCK10 ARID1A JMJD1C MS4A4A NF1 PAN3 MBD5 MYO16 | 2.75e-04 | 731 | 145 | 12 | EFO_0007989 |
| Disease | Mammary Carcinoma, Human | 2.83e-04 | 525 | 145 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.83e-04 | 525 | 145 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 2.91e-04 | 527 | 145 | 10 | C1458155 | |
| Disease | colorectal cancer (is_implicated_in) | 3.36e-04 | 121 | 145 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Liposarcoma, well differentiated | 3.55e-04 | 6 | 145 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 3.55e-04 | 6 | 145 | 2 | C0205824 | |
| Disease | eosinophil count | MON2 FOXO1 NRIP1 CUX2 HIVEP2 MCIDAS FOXA1 NACAD HIVEP3 PIK3CD-AS1 HFM1 MBD5 MUC22 SRRM3 MYO16 SMAD4 RBX1 MAF | 3.82e-04 | 1488 | 145 | 18 | EFO_0004842 |
| Disease | cardiac arrhythmia | 4.28e-04 | 30 | 145 | 3 | EFO_0004269 | |
| Disease | Colorectal Neoplasms | 4.57e-04 | 277 | 145 | 7 | C0009404 | |
| Disease | metabolic syndrome | 4.79e-04 | 200 | 145 | 6 | EFO_0000195 | |
| Disease | Irido-corneo-trabecular dysgenesis (disorder) | 4.96e-04 | 7 | 145 | 2 | C0344559 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 4.96e-04 | 7 | 145 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | restless legs syndrome (implicated_via_orthology) | 6.59e-04 | 8 | 145 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | Embryonal Rhabdomyosarcoma | 6.59e-04 | 8 | 145 | 2 | C0206656 | |
| Disease | triacylglycerol 58:6 measurement | 6.59e-04 | 8 | 145 | 2 | EFO_0010440 | |
| Disease | Anterior segment dysgenesis | 6.59e-04 | 8 | 145 | 2 | cv:C1862839 | |
| Disease | nicotine withdrawal symptom count | 6.78e-04 | 35 | 145 | 3 | EFO_0009263 | |
| Disease | Cleft Palate | 6.94e-04 | 81 | 145 | 4 | C0008925 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 7.46e-04 | 301 | 145 | 7 | DOID:684 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 9.71e-04 | 616 | 145 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.71e-04 | 616 | 145 | 10 | C0376358 | |
| Disease | Odontome | 1.05e-03 | 10 | 145 | 2 | C0524730 | |
| Disease | glucagon-like peptide-1 measurement | 1.05e-03 | 10 | 145 | 2 | EFO_0008465 | |
| Disease | Tooth Abnormalities | 1.05e-03 | 10 | 145 | 2 | C0040427 | |
| Disease | Craniofacial Abnormalities | 1.06e-03 | 156 | 145 | 5 | C0376634 | |
| Disease | nucleus accumbens volume change measurement | 1.28e-03 | 11 | 145 | 2 | EFO_0021493 | |
| Disease | platelet component distribution width | FOXO3 CACNA1C NRIP1 HIVEP2 MAMLD1 DOCK10 JMJD1C EDNRA BAZ2A POLK MAF | 1.31e-03 | 755 | 145 | 11 | EFO_0007984 |
| Disease | Adenocarcinoma of large intestine | 1.31e-03 | 96 | 145 | 4 | C1319315 | |
| Disease | Congenital Heart Defects | 1.33e-03 | 44 | 145 | 3 | C0018798 | |
| Disease | anthropometric measurement | 1.48e-03 | 168 | 145 | 5 | EFO_0004302 | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 1.53e-03 | 12 | 145 | 2 | DOID:4914 (is_marker_for) | |
| Disease | cleft palate (is_implicated_in) | 1.53e-03 | 12 | 145 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Neuroblastoma | 1.61e-03 | 47 | 145 | 3 | C0027819 | |
| Disease | Leukemia, Myelocytic, Acute | 1.68e-03 | 173 | 145 | 5 | C0023467 | |
| Disease | blood phosphate measurement | 1.73e-03 | 174 | 145 | 5 | EFO_0010972 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.81e-03 | 13 | 145 | 2 | C0751122 | |
| Disease | Antihypertensive use measurement | 2.04e-03 | 265 | 145 | 6 | EFO_0009927 | |
| Disease | diet measurement | PTBP2 UBAP1 JMJD1C PTPRT SMTN CDH22 DST NF1 MUC17 TNRC6A MBD5 DNAH5 MYO16 | 2.06e-03 | 1049 | 145 | 13 | EFO_0008111 |
| Disease | coffee consumption measurement | 2.10e-03 | 182 | 145 | 5 | EFO_0006781 | |
| Disease | granulocyte percentage of myeloid white cells | 2.16e-03 | 268 | 145 | 6 | EFO_0007997 | |
| Disease | cancer (implicated_via_orthology) | 2.16e-03 | 268 | 145 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | plasminogen activator inhibitor 1 measurement | 2.40e-03 | 54 | 145 | 3 | EFO_0004792 | |
| Disease | Situs ambiguus | 2.41e-03 | 15 | 145 | 2 | C0266642 | |
| Disease | African Burkitt's lymphoma | 2.41e-03 | 15 | 145 | 2 | C0343640 | |
| Disease | liver volume | 2.41e-03 | 15 | 145 | 2 | EFO_0600048 | |
| Disease | RASopathy | 2.41e-03 | 15 | 145 | 2 | cv:C5555857 | |
| Disease | Burkitt Leukemia | 2.41e-03 | 15 | 145 | 2 | C4721444 | |
| Disease | hepcidin:transferrin saturation ratio | 2.41e-03 | 15 | 145 | 2 | EFO_0007902 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.53e-03 | 55 | 145 | 3 | EFO_0004623, HP_0002140 | |
| Disease | factor XI measurement, coronary artery disease | 2.54e-03 | 115 | 145 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | cortical surface area measurement | MON2 FOXO3 SP1 ANO2 SUPT3H SATB2 SAMD9 MYCBP2 DOCK10 MEIS2 FAM168A TOX3 TNRC6A PC MYO16 | 2.62e-03 | 1345 | 145 | 15 | EFO_0010736 |
| Disease | obsolete_red blood cell distribution width | DUSP12 TPP2 SP1 NRIP1 SAMD9 UBAP1 BIRC6 ZC3H11A CCT5 MUC17 ATXN7 NFRKB HFM1 POLK MYO16 | 2.66e-03 | 1347 | 145 | 15 | EFO_0005192 |
| Disease | platelet crit | FOXO1 CACNA1C NRIP1 ARID4B DOCK10 ARID1A CBL JMJD1C EDNRA NF1 HFM1 SMAD4 | 2.66e-03 | 952 | 145 | 12 | EFO_0007985 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 2.77e-03 | 194 | 145 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | Endometrial Neoplasms | 2.94e-03 | 58 | 145 | 3 | C0014170 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.98e-03 | 286 | 145 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.24e-03 | 60 | 145 | 3 | EFO_0022233 | |
| Disease | platelet-derived growth factor BB measurement | 3.40e-03 | 61 | 145 | 3 | EFO_0008264 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.40e-03 | 61 | 145 | 3 | DOID:3587 (is_marker_for) | |
| Disease | cortical thickness | MON2 FOXO3 SP1 ANO2 SUPT3H SATB2 COL12A1 MYCBP2 PTBP2 JMJD1C TOX3 TNRC6A MYO16 | 3.42e-03 | 1113 | 145 | 13 | EFO_0004840 |
| Disease | hippocampal volume | 3.58e-03 | 297 | 145 | 6 | EFO_0005035 | |
| Disease | pulse pressure measurement | FOXO3 NRIP1 CUX2 NEBL UBAP1 MEIS1 EDNRA HIVEP3 ZNF827 ATXN7 YAP1 TNRC6A NPRL3 MBD5 RBX1 | 3.62e-03 | 1392 | 145 | 15 | EFO_0005763 |
| Disease | Malignant neoplasm of stomach | 3.76e-03 | 300 | 145 | 6 | C0024623 | |
| Disease | Juvenile Myelomonocytic Leukemia | 3.88e-03 | 19 | 145 | 2 | C0349639 | |
| Disease | leukemia (implicated_via_orthology) | 3.88e-03 | 19 | 145 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 3.88e-03 | 19 | 145 | 2 | DOID:4928 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.89e-03 | 64 | 145 | 3 | DOID:4947 (is_marker_for) | |
| Disease | verbal-numerical reasoning measurement | 4.05e-03 | 131 | 145 | 4 | EFO_0008394 | |
| Disease | Deaf Mutism | 4.30e-03 | 20 | 145 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 4.30e-03 | 20 | 145 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.30e-03 | 20 | 145 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.30e-03 | 20 | 145 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.30e-03 | 20 | 145 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 4.30e-03 | 20 | 145 | 2 | C0011052 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.42e-03 | 67 | 145 | 3 | C3463824 | |
| Disease | alkaline phosphatase measurement | SUPT3H CUX2 SAMD9 UBAP1 JMJD1C HIVEP3 NF1 ZNF827 YAP1 HFM1 MUC22 MAF | 4.44e-03 | 1015 | 145 | 12 | EFO_0004533 |
| Disease | serum IgG glycosylation measurement | 4.44e-03 | 523 | 145 | 8 | EFO_0005193 | |
| Disease | Sarcoma | 4.74e-03 | 21 | 145 | 2 | C1261473 | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.74e-03 | 21 | 145 | 2 | cv:C5680330 | |
| Disease | urate measurement | CUX2 NEBL DDR2 ARID1A BIRC6 JMJD1C PTPRT ZNF827 HFM1 MBD5 PC | 4.80e-03 | 895 | 145 | 11 | EFO_0004531 |
| Disease | congenital heart disease (implicated_via_orthology) | 4.81e-03 | 69 | 145 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Nonorganic psychosis | 4.81e-03 | 69 | 145 | 3 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLTLAEPSMSSASQN | 1291 | Q4LE39 | |
| EPSMSSASQNGMSVE | 1296 | Q4LE39 | |
| STPAMMNGQGSTTSS | 241 | Q6ZN18 | |
| PLMSQMSGSVTASMA | 206 | Q9Y6F7 | |
| MSGSVTASMATGSAT | 211 | Q9Y6F7 | |
| LTLMTNMQLNSGSSS | 2726 | Q9NR09 | |
| SGPMSEMSSIPVNNS | 1556 | Q8IZF6 | |
| EATMDTTMAPNSLQT | 411 | Q9NP70 | |
| QTATMSPDMNTCTSD | 781 | Q6ULP2 | |
| MKMELAGSNTTASSP | 1171 | Q9UIF9 | |
| SMNSDSSFPGISIME | 566 | Q96GX5 | |
| SPQMGSMTFEDTSNF | 336 | A8K2U0 | |
| MNSSTSTMSEEPDAL | 1 | Q9NVT9 | |
| LMAMGTTSPQLSLSS | 966 | Q69YQ0 | |
| SKSLMTSVPMNGTSI | 391 | P25101 | |
| SSAPSGQSQLGSMMS | 981 | Q9NQ90 | |
| VTNQMTADPGATMTF | 266 | Q14565 | |
| NSPSAASSPGLMMSV | 1396 | O14529 | |
| SFTPTTQLSMNLAMA | 91 | P00846 | |
| LSTASQMSSVSMASG | 796 | Q5T5Y3 | |
| PQDTSLFTMQTDQSM | 406 | P49418 | |
| MAAAMDVDTPSGTNS | 1 | P62877 | |
| MNGSNMANTSPSVKS | 1 | Q9ULR5 | |
| SMDTNSSGMSSLINP | 596 | Q9NZL6 | |
| DMIMSSATGNATNSS | 256 | Q8N130 | |
| TNAMAPSMGSSVNDA | 56 | O00470 | |
| GQSDSIMHPSMNQSS | 731 | O14497 | |
| MNSQPMGTSGTTSTG | 381 | P26367 | |
| NTSVTSMGSQMPDHD | 936 | Q8TAB3 | |
| EETSSGFSLMSPSMT | 5626 | Q8WXI7 | |
| SFSRTSMSGPEQSTM | 7581 | Q8WXI7 | |
| SMSGPEQSTMSQDIS | 7586 | Q8WXI7 | |
| ETMMTQPTSSLTSGL | 8696 | Q8WXI7 | |
| MTQVMSSSRGPSPDQ | 9036 | Q8WXI7 | |
| RDNMVSTTMPGSSGI | 9556 | Q8WXI7 | |
| STMSQGLSHSEMTNL | 9691 | Q8WXI7 | |
| TQMATSASIHSMPTG | 1861 | Q6W4X9 | |
| MASELAMSNSDLPTS | 1 | O75444 | |
| TTMAMSAGTLLTTPQ | 201 | Q92567 | |
| GPSEQSQMSLSDSSM | 701 | Q6P4R8 | |
| NTGSSRSVMTQMSSS | 701 | Q6ZRS4 | |
| TASSSVTMAPGMDFT | 1566 | E2RYF6 | |
| ETGPVSMGTNTVSMS | 1631 | E2RYF6 | |
| SMGTNTVSMSHTPTN | 1636 | E2RYF6 | |
| SQDSIPENPMMSGST | 376 | Q9Y6X6 | |
| MTVSLSLPSDSSMFN | 441 | Q16832 | |
| SDSQMSDSSGVSPMT | 3196 | Q03001 | |
| NMALAGTASMAPNST | 326 | Q8IYT1 | |
| TMSAQSPTMLNSVDP | 451 | O14770 | |
| SSTKTDSMPAMQLAS | 1311 | Q15652 | |
| STGSTKSFNMMSPTG | 636 | B1AK53 | |
| PQSHMAEMTGSTQAS | 161 | Q8IYD8 | |
| MNEDGPSMSVNFTSP | 146 | Q9NRM6 | |
| RTLMSSGQMAPSSSN | 631 | Q5VYK3 | |
| GMMSRFNELPNSDSS | 891 | Q9UHC1 | |
| NSSTSMAPTFLLVGM | 11 | Q8NGJ8 | |
| MTLTSPSMDNSSAEL | 456 | Q12980 | |
| MTQSPSAMSASVGDR | 26 | A0A075B6S4 | |
| LNGLMYSSTQPSSCM | 981 | P48552 | |
| MLGQSSVHQMTPSSS | 1921 | Q93074 | |
| MMAVNSSSPTAACSG | 141 | Q7L4E1 | |
| QSSMNAMGSLSVLSP | 721 | Q92616 | |
| SVQGQSVMMISPSSE | 636 | Q7Z3U7 | |
| MSVMVNSSDSTLSLG | 791 | O15265 | |
| DTSRSTNPVTFMSNM | 156 | Q9HCN4 | |
| ISDSSSMMSPTLASG | 126 | D6RGH6 | |
| SAGMIDSATPISMAS | 221 | Q99853 | |
| DQAVPTGSFMMVNSS | 66 | O14522 | |
| PSTSKMNAQETATGM | 406 | O43719 | |
| MQRMNSCNSSSFGPS | 131 | P17509 | |
| LSPASLDSMSGNVTM | 866 | Q5T6X5 | |
| LDSMSGNVTMTNPSS | 871 | Q5T6X5 | |
| SLSNSAMPKFSASSM | 1336 | A2PYH4 | |
| SMDSDNSMSVPSPTS | 526 | P51003 | |
| PLMQRMTNSSSSPSL | 181 | Q58A45 | |
| PANGEMSSSHSAQSM | 461 | O15350 | |
| NTMTTSGNMTPASFN | 51 | P55317 | |
| QGSLSAPSMQNMETS | 1516 | Q92794 | |
| TQGYISMSQPSQMSQ | 1066 | Q92900 | |
| NVMSTATSPLMGAQS | 1581 | Q9ULT8 | |
| SLTVSTQSSPGTMMQ | 386 | Q12778 | |
| PRNMSMPTSETESVN | 461 | Q13936 | |
| NSLLTTPSGGSMFSM | 1761 | Q96BY6 | |
| SVLSQMSFASQSMPT | 1746 | Q92608 | |
| QISVSAMKGMTSSEP | 401 | Q99715 | |
| NATPMNSATISTMTP | 121 | Q9H1M3 | |
| TGTNENADSMTSMST | 1846 | Q8TD84 | |
| SQSTGMTGMSYRSQP | 106 | Q5SR53 | |
| MFLMPTSSELNSGQN | 1 | Q9HC77 | |
| SPDQSSMPMSNVGTT | 871 | Q86UU0 | |
| PPLNMNSSTTLSNME | 1026 | Q86UU0 | |
| LLQGASTQASSMSMP | 301 | O43303 | |
| STQASSMSMPVLASF | 306 | O43303 | |
| VSSANMMSGISSVPT | 346 | P68400 | |
| SPQSLMVSCMSSNTL | 361 | Q13495 | |
| PEESTFSAAMTTMQG | 11 | Q96JQ5 | |
| LQNAQMSSLGSFPMT | 106 | Q9NUK0 | |
| RSSSTSSDHGNFMMP | 461 | Q9P267 | |
| FSLDTSMSMNSSPLV | 641 | P22681 | |
| SPTGTSVMQVMASDA | 181 | Q9UJ99 | |
| MTPSSMLTTGRQAQC | 251 | Q9UNI6 | |
| MMCSRVPSEQSSGTS | 1 | Q96BU1 | |
| DSQAAEMPIGSMTAS | 516 | Q504Y0 | |
| SPATVSRNGMVFMSS | 2386 | Q8TE73 | |
| DGQMGVSTNSSSHPM | 1326 | Q15648 | |
| ITDMTNALVGMSPSS | 391 | Q12756 | |
| QLSTSSSMTEGSGTM | 841 | Q9UPQ0 | |
| GMTMHSSGNSSSQVP | 1056 | Q12923 | |
| PSANSSTLKDTVMAM | 271 | P47887 | |
| LQVTTMRMSTPSEGS | 3561 | Q685J3 | |
| NSSINATTVMPTMPS | 926 | P22897 | |
| MTQSDPLMSQASTAV | 486 | O43524 | |
| TSGAMSTPLMTAQTS | 571 | Q8NET4 | |
| SGAMSTSQMTATVSG | 676 | Q8NET4 | |
| TSQMTATVSGGMSMP | 681 | Q8NET4 | |
| MSSTVNNGAASMQST | 1 | A6NNA2 | |
| SGSVLSSPNSNMSSM | 21 | Q9UKA9 | |
| SSPNSNMSSMVVTAN | 26 | Q9UKA9 | |
| TQQRSSDMSLPDSMG | 6 | Q5JRV8 | |
| PSDPGSGTATMMNSS | 1726 | Q5JRA6 | |
| DMANPSAMSTTAKGS | 121 | Q5K651 | |
| TMSTEQARSGEGPMS | 1031 | P21675 | |
| MDNMSITNTPTSNDA | 1 | Q13485 | |
| MCNTNMSVPTDGAVT | 1 | Q00987 | |
| MNPNVSMVSSASSSP | 441 | Q9UPW6 | |
| ALSENSGMNPIQTMT | 461 | P48643 | |
| SDLMMSLPSGSSLQQ | 3661 | O75592 | |
| SSQSMFSPPNSISSM | 206 | Q99697 | |
| SSSGSPASVMTNMRA | 281 | Q15714 | |
| MSSQLPDTPNSMVAS | 331 | P61371 | |
| TTTSNMGIMNFTTSG | 331 | P08047 | |
| MPSSTAMAVGALSSS | 1 | Q2TAL6 | |
| NSTSSQLMMNGATSS | 556 | O15062 | |
| LDSGTEMPALTSSQM | 326 | Q9NZ09 | |
| MNNTAASPMSTATSS | 1 | O75486 | |
| SMNSTDQESMNTGTL | 491 | A6NCW7 | |
| SSNSSQSLAPLMMEV | 396 | Q9Y458 | |
| VSASSKEPAMSMNSA | 916 | O75717 | |
| EVSGPSSSQMSMKTR | 741 | O75152 | |
| KPIAVGSMSMLSTSN | 126 | Q9UBT6 | |
| MESTLSASNMQDPSS | 1 | Q5VUG0 | |
| ASSCSMSSQSMPGLP | 1926 | Q5T1R4 | |
| GTQLMNGTSMSSPNA | 441 | P29144 | |
| SSPGMSQELRTMTTN | 366 | P46937 | |
| GCDIPSSGNTSQMSM | 631 | P21359 | |
| SMISVMSSEGNADTP | 876 | P21359 | |
| QQMAGMSISSATPTA | 426 | Q8IYB5 | |
| MDRSGSMQSPMSSQD | 286 | O00534 | |
| SMQSPMSSQDTSQLR | 291 | O00534 | |
| VMSSSGTTNQTPMQI | 676 | Q68DE3 | |
| VSTSSMNTVACLPNM | 776 | Q68DE3 | |
| ISSMGTTMVGSAPST | 416 | O15405 | |
| GSQMSTDTMVSNPMF | 486 | Q86X10 | |
| TQISNMPFMDESSGS | 481 | Q9ULM0 | |
| MMTSNTPERTSQGGA | 501 | Q17R98 | |
| SGSSMAPIMTTVQSK | 346 | Q9HBG4 | |
| MINSNTYESSGSPML | 1086 | Q86YA3 | |
| SMNSTDQESMNTGTL | 491 | P0C7I0 | |
| MLCMANLQSSSSSPA | 761 | Q9UPP1 | |
| SNSEPSMNSDMGKVS | 626 | Q9HBM0 | |
| SDMSMSPQSSSLPAG | 1576 | P31629 | |
| TPSSGMSSTMKESAF | 1731 | Q5T4S7 | |
| VAADSMSGMTSQPSM | 796 | P11498 | |
| ENGSGSTMMQTKTFS | 696 | P53814 | |
| LATSSMDSQMLASGT | 856 | P18583 | |
| ITTEMTGPNNTTNFM | 446 | Q8NDV7 | |
| QFMSSQSMKLPPSNS | 1291 | Q8NDV7 | |
| TDSTAGQESAAMAMP | 511 | O15069 | |
| QTSVSSMRSMQHSPN | 941 | O76041 |